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ABSTRACT
EFFECT OF TEMPORAL ONSET OF MECHANICAL LOADING
ON TENDON TO BONE HEALING,
DETERMINED WITH A NOVEL IN-VIVO DEVICE

by Mark E. Stasiak

Advisor: Professor Luis Cardoso

Background: Exposure to tensile loading has been shown to maintain tendon/ligament homeostasis,
with the tensile modulus of the tissue increasing in response to greater loading frequency, and even
decreasing in the absence of load. However after injury or surgical repair the effect of tensile load is
controversial, with many studies implicating mechanical loading with impaired healing. It is currently
unknown when the tensile loading imparted during rehabilitation exercise, can be safely reintroduced
after surgical tendon repair or ligament reconstruction, and at what time point it can most benefit the
remodeling process. To investigate the effect of tensile loading protocols on tendon graft to bone tunnel
healing, we developed and validated a novel device to cyclically distract the knee joint in a rat model of
anterior cruciate ligament reconstruction (ACL_R), thereby imposing a controlled amount of tensile
strain on the tendon graft. Using this device we tested the following hypotheses; H0 which predicts that
the immediate resumption of tensile load after ACL_R surgery will impair tendon-to-bone healing
compared to continuous knee immobilization. And H1 which predicts that after ACL_R surgery, insertion
of a of 4 to 10 day load shielding period, prior to the resumption of tensile load, will improve tendon-tobone healing compared with both immediate load resumption or continuous immobilization.
Methods: Male Sprague Dawley rats who had undergone ACL_R surgery via a flexor digitorum longus
tendon auto-graft were randomly assigned to either; 1) a continuous-immobilization group to strain
iv

shield the graft or a cyclic knee distraction group using the device to achieve two-percent strain of the
tendon graft. The animals receiving cyclic knee distraction were further subdivided into; 2) an
immediate-loading group beginning on postoperative day one, 3) a four-day delayed-loading group
beginning on postoperative day four, and 4) a ten-day delayed-loading group beginning on
postoperative day ten. The above experiment was were repeated with the device applying ten-percent
strain to additional four-and ten-day delayed-loading groups. All animals were sacrificed on either
postoperative day fourteen or twenty-eight for immuno-histochemical, biomechanical, and microcomputed tomography analysis of the femur-graft-tibia complex.
Results: Immediate-loading, beginning on postoperative day one did not result in a significantly reduced
load-to-failure mechanical response or bone tunnel volume, compared with continuous-immobilization.
However a significantly greater number of inflammatory macrophage cells in the immediate-loading
group provided partial support for hypothesis H0. The data supported hypothesis H1, with the four- and
ten-day delayed-loading groups having significantly less inflammatory macrophages and more new
bone volume at both two and four weeks. The failure load of the femur-graft-tibia complex was
significantly greater in the ten-day delayed-loading group at two weeks, and in the four-day delayedloading group at four weeks. Repeating the experiment with cyclic knee joint distraction increased to
ten-percent of graft length did not recapitulate the significantly greater failure loads in the delayed
loading groups.
Conclusion: On the basis of greatest failure load, most bone tunnel ingrowth, and lowest inflammatory
cell population, the four-day delayed-loading protocol was judged most effective for tendon-to-bone
healing in the rat model of ACL_R. These parameters could be extrapolated to a human clinical trial of an
improved ACL rehabilitation protocol, provided a careful choice of knee exercises applying a maximum
of two-percent tendon graft strain were made.
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Chapter 1:
General Introduction
Surprisingly, a literature search of the phrase “tendon to bone healing” returns little on intrinsic
tendon healing. Rather, the results reflect current research interest in the mechanisms of incorporation
after the surgical apposition of tendon onto bone. Lacerations and ruptures that fail to heal after
conservative treatment often require surgical reattachment of tendon to bone. Additionally, nonhealing ligament ruptures of the knee are typically reconstructed using tendon grafts due to the
structural and mechanical similarity between tendons and ligaments. In either case, repair or
reconstruction, the outcome depends on successful tendon to bone healing [1,2].
The simplicity of the phrase also belies the difficulty of the task from an engineering standpoint.
It requires the union of two dissimilar materials; flexible fibrous tendon with a Young’s modulus of 200
MPa solely in tension, onto rigid, brittle bone, with a 20 GPa modulus in both tension and compression.
This results in a second order of magnitude disparity in the stress-strain response across the interface,
creating stress concentrations and a propensity to delaminate as one material deforms significantly
more than the other under identical loading [3].
Operations depending upon effective tendon to bone healing can have varying success rates. Of
the more than 250,000 operations each year in the US to repair rotator-cuff tendon tears of the
shoulder, an estimated 50 % experience re-tears, with a disproportionate effect on the elderly and their
quality of life [4]. The gold standard of care for a ruptured anterior cruciate ligament of the knee, is
surgical reconstruction with a tendon graft, and generally achieves good results. However rates of
revision surgery in young and active patients are as high as 20 %. Poor tendon to bone healing after ACL
reconstruction (ACL_R) can increase knee laxity and predispose the patient to early osteoarthritis [5–7].
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While the ACL is a knee ligament and the rotator cuff tendons control humeral head position in
the shoulder, they both share a similar structure in their attachment sites to bone and a common
synovial joint environment [8]. Unfortunately they also share a poor propensity to heal, reasons for
which will be given in chapter II, and both typically require surgical repair/reconstruction upon injury
and depend on effective tendon to bone healing for rehabilitation.
The weakest link in a healing ligament reconstruction is not the tendon graft itself, but at its
point of attachment to the bone [9]. Failure here is more likely to occur than at a mid-substance. After
the initial surgical placement, the interface between tendon graft and bone is rapidly filled with an
amorphous granulation tissue during the initial the healing response [10]. Although remodeling of the
interface tissue does occur, it does not replicate the structure and superior mechanical properties of the
native tendon/ligament insertion site, known as an enthesis [2]. Enthesis type, composition and
development, along with the native tendon/ligament wound healing response are described in detail in
chapter II.
Because development of the native enthesis is believed to be driven both by genetic cues and as
a cellular response to mechanical loading during joint movement, both pre and postnatal, it is thought
that after ligament reconstruction or tendon repair, continued tensile loading of the tendon/graft will
drive remodeling of the interface tissue into an improved approximation of the native enthesis, with a
greater resistant to failure under load [3]. Many studies have been conducted on the augmentation of
tendon and ligament repair/or reconstruction using applied growth factors and genetic vectors, yet the
few studies on the effect of mechanical loading have used activities such as treadmill running where the
applied load on the tendon is difficult to quantify [11–13].
In addition to the basic science questions regarding postsurgical enthesis restoration, there is an
urgent clinical need to ascertain when one can safely resume tensile loading of a vulnerable ligament
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reconstruction or tendon repair [14]. To answer these questions we used a previously developed rat
model of ACL_R [10] and developed a unique joint fixation and loading system to apply a controlled and
quantified amount of tensile load on the healing tendon graft. A rat model of rotator cuff repair was
considered but excluded due to the inability of the thin rat scapula to support a joint fixation device.
This dissertation will detail the design of that system and elaborate on the results obtained using it to
study the role of mechanical load on tendon to bone healing.
Thesis Organization
Chapter two presents tendon and ligament mechanical properties and basic science.
Explanation of the time dependent aspects of these properties is included to aid novice readers
interpreting data from repeated loading. The basic science section covers not only tissue composition
and structure but also embryonic development, to introduce those cell signaling molecules guiding
tissue genesis that may also have a role in repair. The impaired healing response of intra-articular
tendon/ligaments is explained along with the requirement for the surgical reconstruction and
rehabilitation addressed by this research. Chapter two concludes by framing the hypotheses and specific
aims governing this thesis.
Chapter three details design and validation of a device to provide in-vivo tensile loading of a
tendon graft ACL reconstruction, modeling the effect of a rehabilitation exercise protocol on the tendon
to bone tunnel healing.
Chapter four will use this device to evaluate the effect of immediate knee motion post ACL_R,
and compares it with the effect of continuous knee immobilization.
Chapter five explores the effects of short periods of immobilization prior to the daily knee
motion protocol and compares the effects with the data obtained in chapter four.
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Chapter six will investigate the effect of increasing the strains applied by the knee distraction
device to the tendon graft.
Chapter seven will summarize and evaluate the results, and suggest future research directions.
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Chapter 2: Tendon & Ligament
Introduction
While bone provides the rigid support for a body and muscle the power necessary for its
locomotion, tendons and ligaments tie the musculoskeletal components into a unified ambulant system.
With their morphology determined by the loads they transmit and resist; formed into flexible, fibrous
cables and straps, or even wide flat bands, their appearance pale from a limited blood supply, and of a
similar internal composition and structure to resist tensile stress, tendons and ligaments are the
essential motion enabling skeletal connective tissues [1,15,16].
Ligaments restrain one bone to another, forming flexible skeletal joints. Tendons serve to
connect muscles to bone. Typically within the appendicular skeleton, a shorter tendon suspends a
muscle from its skeletal origin, while at the distal muscle end a longer tendon emerges to insert at the
point of action on a long bone [15]. Both work together as compliments, while a tendon transmits the
force of muscle contraction through its substance, resulting tension in the joint spanning ligaments
constrains and guides the path of skeletal motion. Injured tendons can limit or disable motion, while
injured ligaments result in excessive joint motion that wears the articular surface provoking early onset
arthritis [16,17].
Tendons and ligaments reduce the metabolic cost of locomotion by functioning as elastic
extension springs; when un-loaded they recoil to their original length, helping return the limb to its
starting position. The Achilles tendon and the plantar ligaments of the feet have been calculated to
return as much as 50% of the energy expended during running [18–20]. High water content allows for
their functioning as speed reducing dashpots, braking motion during rapid stops and changes in
direction; the viscous drag force on water exuding from tendon/ligament increases with the speed of
their elongation, absorbing energy to protect the skeleton [17]. Enervation not only senses pain but also

5

enables proprioception. Stretch and pressure receptors in tendons and ligaments provide information
on joint position and muscle contraction and even enable reflexive motion [21].
Ligaments guide joint motion by restricting it more in one plane than another.[17] While the
anterior cruciate ligament (ACL) allows large degrees of knee flexion and extension in the sagittal plan,
its posterior-lateral bundle becomes taught as the tibia rotates internally in the transverse plan, limiting
that motion and preventing one from tripping over their own foot. However, the ACL becomes slack as
the tibia rotates externally and places less restraint on that motion (Figure 2.1 a, b) [22]. Athletic
activities or accidents causing a rapid internal rotation or anterior-posterior translation of the tibia that
stretch the ACL past its ultimate strain (breaking length) are a known mechanism for its rupture [23].
Knee flexion-extension is not just a rotation of the tibia about the femur like a simple pin hinge.
The tibial plateau also slides on the femoral condyles, changing the instant center of rotation of the tibia
throughout the path of knee flexion-extension (Figure 2.1 right). Therefore without a fixed center of
tibial rotation in the femur, the ACL must stretch and twist elastically to accommodate all degrees of
freedom in the knee joint [24].

Figure 2.1, (a) “The ACL is stretched when the tibia is internally rotated relative to the femur, due to its
oblique orientation inside the knee. (b) The ACL is unwound and becomes slack and unloaded with the
tibia externally rotated relative to the femur. Similarly, the ACL may be loaded and unloaded by tibial
6

adduction and abduction, respectively” [22]. Right: Instantaneous center of knee rotation determined
via the perpendicular bisectors of the paths A to A’ and B to B’ and their intersection at the
instantaneous center C. Note that the femur is sliding in the direction of the vector from point D. As the
flexion angle increases, the locations of C within the femur and tibial-femoral contact point D change
[24].

Tendons and ligaments must also resist fatigue failure, an accumulation of tears and damage
from many cycles of loading/unloading that over time reduce the strength and cross-sectional area of a
structure so that it fails unexpectedly at a level far below its expected failure load. Indeed, the
accumulation of unrepaired fatigue damage from endurance exercises and repetitive work tasks,
coupled with an inability of cellular repair processes to keep up, is a proposed etiology for
tendon/ligament degeneration and disorder [25].
Tendon and Ligament Composition
Tendons and ligaments are biological fiber reinforced composite materials adapted to withstand
tensile stresses while retaining flexibility. Their dry weight consists of from 65 to 75% collagen fibers
with a predominantly longitudinal orientation, adjusted to resist the unique tensile stresses at each
tendon/ligament’s specific anatomical location. The collagen fibers are surrounded in an amorphous
matrix or ground substance composed chiefly of water and proteoglycans that add time dependent
viscous properties and provide lubrication for the fibers to glide over each other [1,17]. Sesamoid bones
can arise within a tendon where it slides over a bone prominence and the resulting change in direction
of tensile force creates a component of compressive force acting on the tissue. Sesamoids serve as
friction reducing glides and can provide a fulcrum for mechanical advantage. The patella (knee cap) is a
sesamoid bone within the quadriceps tendon/patella ligament that provides a fulcrum for the
quadriceps muscle during knee flexion/extension while gliding over the articular cartilage surface of the
trochlea, located in between the condyles of the femur [26].
7

Tendon and Ligament Mechanical Properties
•

Force Displacement Relation
If a representative specimen of tendon or ligament is stretched to failure at a constant rate, a

plot of the internal force – elongation relation will at first increase slowly, and then gradually begin to
curve upward as the internal force grows faster with each equal increment in specimen length. This
initial upward curve of the plot is called the toe region and represents the gradual recruitment and
alignment of the collagen fibers within as they begin to resist the stretching; it requires an exponential
function to represent it mathematically (Figure 2.2). The toe region ends as the slack is taken up from all
collagen fibers, now each equal increment in specimen length adds the same proportional increase to
the internal force, represented mathematically as: F = k*x. The plotted force-elongation relation is now
a straight inclined line, the constant slope of which is known as the stiffness. The stiffness is due to the
material and structural properties of the collagen fibers and other components of the extracellular
matrix (ECM) and its magnitude correlates with the amount, thickness and quality (the extent of
chemical crosslinking) of the fibers in the specimen [16,17].

Figure 2.2: Typical force versus elongation relation for a tendon or ligament. The slope (or stiffness) of
the curve can increase with the rate of elongation of the tissue.
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A specimen’s stiffness can be divided by its cross sectional area and then multiplied by its
original length, giving its modulus of elasticity (stress/strain) in units of Pascals (N/m2). This
normalization allows one to compare tendon or ligament specimens from animals differing in size or
weight and even make comparisons across species. Unfortunately the non-contact devices required to
accurately measure the irregularly shaped and compliant cross sectional areas of tendons and ligaments
are costly and not available in many laboratories [27–29].
As stretching of the specimen continues, eventually some of the collagen fibers begin to break
or slide past each other and the internal resisting force stops increasing with added length. The curve
has reached a plateau and the specimen will not recoil to its original length if released, its elastic
behavior has been permanently lost. More fibers begin to break or slide and the specimen will soon
completely fail. The highest force reached is its load-to-failure force (ultimate strength, if normalized)
[16,17].
Tensile testing of human cadaver ACL specimens revealed decreasing structural properties with age, as
shown in the table 2.1 below of failure load and stiffness by age group [30]. Specimens consisted of the
native femur-ACL-tibia complex with all surrounding soft tissue removed:
Table 2.1: Human Cadaveric Anterior Cruciate Ligament
Age Group (years)

Failure Load (N)

Stiffness (N/mm)

Young Adult (22 - 35)

2,160 ±157

242 ± 28

Middle Aged (40 - 50)

1,503 ± 83

220 ± 24

Older (60 – 97)

658 ± 129

180 ±25

For comparison with the subjects used in our studies, a control group of eighteen week old
female Sprague-Dawley rats had a mean failure load of 26.7 ± 8.6 N and a stiffness of 41.3 ± 19.3 N/mm
[31].
9

•

Force-Time & Strain-Time Relations:
Stress relaxation (force relaxation without normalization) occurs when a tendon or ligament

specimen is suddenly stretched and held to a constant length within the linear elastic region for an
extended period. (Instantaneous elongation and infinite duration are required parameters for
mathematical modeling.) As time elapses the internal force will gradually decrease, without any
corresponding reduction in length, falling in ever smaller increments to approach but never quite reach
a steady state level. A plot of the internal force over time would show a curvilinear drop to approach a
horizontal line (Figure 2.3 a) [16]. This is due to the gradual loss of specimen fluid content over time,
while the steady state level of internal force (f0) reflects the static elongation of the collagen fibers (f0 =
k*x) [16].

Figure 2.3: A. Force relaxation curve in tendon or ligament. The force required to maintain a constant
length decreases over time until a steady state level is reached. B. Creep curve - If held under a constant
tension, a tendon or ligament will slowly lengthen (creep) until reaching a steady state length.
Conversely, if we held external force on the specimen constant - while allowing its length to
vary; say we suspended a weight from its free end. After an initial rapid stretch we would observe the
specimen continue to lengthen under constant weight, but in ever diminishing increments. A plot of
elongation over time (Figure 2.3 b), would show an initial rapid curvilinear increase, slowing to approach
a horizontal limit on specimen length, reflecting the time independent response of the collagen fibers to

10

the constant weight (x = f/k). This continual but gradually diminishing elongation of tendon/ligament
under constant tension is known as creep; due to the gradual decay of the viscous component of the
internal force as less and less water bleeds out of the tissue until all that is left is the elastic component
of the collagen fibers [16].
•

Hysteresis and Energy Loss
Stretching a tendon/ligament specimen to a length not exceeding the linear region of its force-

elongation curve, then allowing it to recoil to its original length yields a contraction force-elongation
curve lower in force at every length point than the initial stretching curve. This decrease in force is
known as hysteresis and represents the energy lost as heat through the viscous component of the
specimen. The area in the loop between the upper “loading” curve and lower “unloading” curve
represents the total energy not recovered during recoil to original length. Most reports of tendon and
ligament hysteresis have been in the range of 5 to 25 % energy lost out of the total work performed. The
total area below the unloading curve is called rebound resilience and represents the amount of the
initial strain energy recovered by elastic recoil. Rebound resilience helps the Achilles tendon and the
plantar ligaments of the foot reduce the cost of locomotion [16,17,19,20].

Figure 2.4: Hysteresis, the energy lost after stretching an elastic specimen and then allowing it to return
to its original length. The total energy lost is the area between the upper elongation curve and the lower
contraction curve (Note: the x-axis must be deformation to calculate the energy loss).
11

Extracellular Matrix: Collagen Fiber Synthesis and Composition
The formation of a collagen molecule requires the cellular synthesis of three individual
polypeptide α-chains, of type α1 or α2. This process begins within the fibrocyte nucleus, with the
transcription of three sequences of messenger ribonucleic acid (mRNA) nucleotides, from the genome
deoxyribonucleic acid (DNA) molecule; one mRNA strand for each α-chain. During transcription, the
double strands of the DNA molecule separate at the gene section encoding the required α-chain type,
and essentially an RNA polymerase reads each subsequent nucleotide from the DNA template strand
and matches it with its complementary nucleotide on the growing mRNA strand. Upon completion each
of the three mRNA strands, essentially blueprints for each α-chain, are transported out of the nucleus
and attached to a ribosome on the rough endoplasmic reticulum (RER), for peptide assembly [32–34].
In a process known as translation, the ribosome reads each subsequent sequence of three
nucleotides - a codon, from the attached mRNA strand. Each codon refers to a specific peptide type,
delivered to the ribosome by transfer RNA (tRNA). The order of the codons determines the order in
which the ribosome links together the different peptides, ensuring that the specific α chain; α1 or α,
encoded by the mRNA strand is produced [33].
In each α chain, the first peptide added is known as the N-terminus because it contains a free
amine group (NH2) that marks the start of the chain. The last peptide added is known as the C-terminus
and contains a carboxyl group (COOH) marking the chain’s end. The body of each α-chain consists of a
repeating sequence of three peptides that conforms into a left handed helix, with the small amino acid
glycine in every third position and the other two positions X and Y frequently occupied by amino acids
proline and lysine. The N- and C- termini at each end are non-helical (Figure 2.5) [33,35].
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α - chain sequence:

Start

X
X
X
X
NH2 - - Glycine – ↗ ↘Y – Glycine –↗ ↘Y … … … Glycine – ↗ ↘–Y Glycine – ↗ ↘Y - - COOH End

Non Helical ¦← - - - - - - - - - - - - - - - Left Hand Helix @ 300 nm long - - - - - - - - - - - - - - - -→¦Non helical
Approximately 330 peptides
Stasiak 2015

Figure 2.5: Molecular arrangement of a typical α-chain. X &Y refers to either proline or lysine [33].
After creation the three new alpha chains thread into the lumen of the RER for post translational
modifications. Many of the proline and lysine residues on the chains are hydroxylated by ascorbic acid
dependent enzymes to form hydroxyproline and hydroxylysine. Some of the hydroxylysines are also
glycosylated with the monosaccharides glucose or galactose (Figure 2.6). These modifications of proline
and lysine are essential for the formation of molecular crosslinks needed to assemble the staggered
hierarchical structure of the future collagen fiber. Variations in post translational modifications can
result in differences in composition and tensile strength between collagen fibers of the same gene. This
explains how vitamin C deficiency can affect diseases of poor collagen quality such as scurvy [33,35].
After post translational modifications are complete, the non-helical C-terminal of one α-chain
folds, allowing it to align with recognition sequences within the C-terminals of the other two α-chains
[34]. Starting from the C-terminal ends, the helical portions of each of the three chains wrap around
each other into a right handed super-helix, forming the procollagen molecule [34,35]. Formation of this
triple helix is possible only if glycine occupies every third position in each alpha chain, because it is the
only amino acid small enough to fit within the central axis of the triple helix [33]. The right handed
winding of three left hand helixes about each other is analogous to modern techniques used increase
the tightness of wound steel cables, and reduces the ability of the three α chains to slip past each other.
The extent of proline hydroxylation determines the stability of a collagen molecule because it enables
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cross-links between adjacent alpha chains. When two α1 chains wrap with one α2 chain the resulting
procollagen molecule is classified as collagen type I, the predominant collage type in tendon and
ligament [33–35].
The path of the new pro-collagen molecule from the RER to the Golgi complex is unclear since
its 300 nm length goes well beyond the 60-80 nm diameter of the typical transport vesicle [35]. (See
Figure 2.6). Within the Golgi complex oligosaccharides are added, yet it is not a completed collagen
molecule because it still contains the non-helical C-terminus ends and possibly the N-terminus ends.
From the Golgi it is transported, (the method again is unclear) along microtubules to the plasma
membrane where it is extruded from the cell [33,35] (Figure 2.6).
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Figure2.6: Synthesis of Collagen alpha chain, (from Junqueira L. Basic Histology, 1992).
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Extracellular Matrix: Collagen Fiber Self Assembly
Within the cell, persistent attachment of the C terminus has kept the procollagen molecules

soluble, preventing them from aggregating into too large of a structure. Once outside the cell, or within
an elongated vacuole on the outer plasma membrane, metalloproteinases cleave the non-helical C and
remaining N termini from the pro-collagen triple helix. The C-terminus is removed by bone morphogenic
protein 1 (BMP1) and the N-terminus by ADAMTs – a disintegrin and metalloproteinase with
thrombospondin motifs. With removal of the N and C termini, it is now a tropocollagen molecule,
completely helical along its approximately 300 nm length and 1.5 nm diameter [35,36].
As more tropocollagen molecules accumulate outside of the cell they align in parallel, with the
cleaved helical ends of the tropocollagen in each row each offset from the helical ends in the adjacent
row by approximately 44 nm, creating a lengthwise-staggered arrangement (See figure 2.7). This is due
to the action of lysyl-odixase, which adds aldehyde groups between tropocollagen rows, crosslinking the
alternating lysines and hydroxylisnes of the adjacent molecules together with strong covalent bonds. It
is the arrangement of the crosslinks that forces the lengthwise offsets between adjacent rows [35,37].
Simultaneously with the crosslinking, electrostatic forces wind the parallel tropocollagen
molecules about a longitudinal axis into a left hand super-super helix, forming the beginning of a
microfibril 3.5 to 4 nm in diameter. The stability of the microfibril increases with the number of
hydroxylysine crosslinks formed between the chains. As the microfibril grows in length, the 44 nm
staggering between the end of one tropocollagen molecule and the next, creates a regular series of
gaps. Stains used in histology readily accumulate within these gaps making them easily visible on
electron micrographs, where they appear as railroad track like cross striations with a regular periodicity
of 67 nm [34], (See Figure 2.7).
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Figure 2.7: Self aggregation of collagen molecules into a fibril (Junqueira L. Basic Histology 1992).
The self-assembly of cleaved tropocollagen into collagen fibrils can be verified easily in vitro.
Collagen fibers are easily dissolved into individual molecules within a mild acid solution. When the
solution is neutralized and warmed, the molecules readily assemble into fibrils. However these fibrils
coalesce into a random mesh with no preferred orientation. This isotropic structure is unsuitable for
tendon and ligament, which depend on a predominantly parallel orientation of fibers to resist tension
along their lengthwise axis. Embryonic development of tendon must somehow rely on cellular
involvement, however cultures of collagen I synthesizing fibrocytes in vitro do not produce longitudinally
ordered ECM [34,36].
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Extracellular Matrix: Embryonic Alignment of Collagen Fibers
Canty et al. have produced evidence that fibrocytes can cleave the C-termini from tropocollagen

molecules within the cell. The activation cascade for metalloproteinases BMP1 and ADAMTs can occur
not only on the cell surface, but also in the secretory pathway, within the “trans-Golgi network’ (TGN) an
apparatus large enough to transport procollagen molecules. The N-terminus is likely cleaved first, within
or just after leaving the Golgi apparatus. Cleavage of the C-terminus occurs afterwards, possibly within
“Golgi to plasma membrane carriers”(GPC) [38].
Normally this would result in the spontaneous assembly of tropocollagen molecules into an
uncomfortably long microfibril within the cell membrane. However an elongated vesicle termed a
“fibropositor” fuses with the cell membrane providing both space for microfibrils to grow and a tube to
extrude them parallel with the fibrocyte’s length (See Figure 2.8). These fibropositors are aligned with
the long axis of the spindle shaped fibroblasts found in tendon and ligament and always parallel with the
length of the tendon/or ligament. The distal external end of the fibropositor has a larger diameter to
accommodate a microfibril growing in into a fibril, which is eventually extruded distally [39].
Fibropositors occur only during a narrow window in embryonic development, when the
fibroblasts are stacked in rows to establish the tissue architecture. Unfortunately, according to current
knowledge, fibropositors cease to occur postnatal and are unavailable to participate in the repair of
injured tendons and ligaments [39].
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Figure 2.8 (A) Transverse sections through a branched fibripositor showing an enclosed GPC (left-hand
side arm) and another that is open to the ECM (right-hand side arm). Fibrils are depicted as black lines
within the lumen of the fibripositors. Blue arrows point to the same fibril in the electron micrographs
and in the schematic. A bar shows the height of the fibripositors. (B) A gallery of electron micrographs in
which mouse tail tendons had been treated with HRP and DAB before preparation for EM. Darkly
contrasted compartments indicate the presence of HRP (closed arrowhead). Compartments lacking HRPreactive DAB (simple arrowheads) [39].

•

Extracellular Matrix: Ground Substance
The ground substance surrounding and filling the spaces between collagen fibers and cells in

tendon and ligament is a viscous, amorphous, transparent gel, 60 – 80 % of which is composed of an
electrolytic water solution. Its viscosity provides lubrication allowing the collagen fascicles to slide past
one another and also serves as a barrier to bacterial invaders. The ground substance helps compensate
for the tissue’s lack of vasculartiy by providing a medium for carbon-dioxide-oxygen exchange and for
the diffusion of nutrients required by cellular metabolism [40].
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Within the ground substance is a complex mixture of three classes of macro-molecules: 1.
glycosaminoglycans, 2. proteoglycans and 3. glycoproteins. Although they account for less than 1 % of
the total dry weight these macro-molecules add to the physical properties of the ground substance,
assist cellular activities, enable the formation of crosslinks between tropocollagen molecules and
facilitate the hierarchical assembly of fibrils [16,40,41].
1) Glycosaminoglycans (GAGs) also known as mucopolysaccharides are very long repeating
chains of disaccharide molecules, typically an amino sugar paired with auronic acid (sugar acid). The
amino sugar can be N-acytel glucosamine or N-acytelgalactosamine, and the uronic acid can be
glucuronic acid or iduronic acid. GAGs are highly negatively charged making them hydrophilic and
polyanionic, binding large amounts of water and cations within the ground substance, and increasing its
viscous properties due to their repeating polymer structure [42].
GAGs are classified into four groups based on their predominant disaccharide component;
Chondroitin Sulfates are composed of glucuronate and galactosamine. Dermatan sulfates are composed
of iduronate and galactosamine. Heparin sulfates are composed of iduronate and glucosamine, and
keratan sulfates have no uronic residues and are composed of galactose with glucosamine. The above
GAGs are synthesized in the Golgi apparatus where they are covalently attached to protein cores
undergoing post translational modifications, together they become part of the second macromolecule,
proteoglycans [42].
Hyaluronic acid is the largest GAG with a molecular mass ranging from 6,500 to 10,900 kDa [43]
and is composed of glucoronate and glucosamine. Because of its extreme length and high molecular
weight of from hundreds to thousands of kilo-Daltons, it must be synthesized by a transmembrane
enzyme complex and dynamically extruded from the cell. Unlike the above GAGs it is uniquely nonsulfated and because of its transmembrane synthesis is not attached to a proteoglycan. Instead, it
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accumulates in the ground substance where with its immense water binding capacity and considerable
viscosity aids in lubrication and also regulates molecular transport by slowing diffusion [41,44–46].
2) Proteoglycans consist of a long core or trunk of proteins translated (linked together) on the
RER. During post translational modification in the Golgi apparatus, side chains of sulfated GAGs and
oligosaccharides are added which branch out from the protein trunk giving it the look of a bottle brush.
Proteoglycans are diverse with differences in the number, length and composition of the added GAG
chains due to enzymatic differences between Golgi complexes. The perpendicular orientation of the
attached GAG chains increases the available surface area for their abundant negative charges to bind
large quantities of water molecules [41,44–46].
Aggrecan and fibromodulin are common proteoglycans in tendon and ligament. The large
proteoglycan aggrecan, can weigh as much as 2,500 kDa, and has about 100 chondroitin sulfate and 60
keratin sulfate GAG chains attached in separate domains along its protein core. These highly negativelycharged chondroitin sulfate chains are arranged along the proteoglycans in a bottle brush format,
increasing their surface area to attract and hold cations and water molecules. This provides the swelling
pressure necessary to support the ground substance and occupy large spaces between collagen fibers.
Many aggrecan proteoglycan chains bind with the even longer GAG, hyaluronic acid to form stable
complexes that contribute to the mechanical properties of the ground substance [45,47,48].
A subcategory, small leucine-rich proteoglycans (SLRPs) includes decorin and biglycan. Decorin
(up to 140 kDa) has a core protein chain of leucine repeats with a single attached GAG chain of
dermatan sulfate. Its leucine core has a high binding affinity for collagen and is almost always found
bound to fibers in vivo. Decorin is believed to regulate fibril diameter, length and organization during
fibrollogenesis [48]. Biglycan has two GAG chains, hence the prefix “bi”. It has a role similar to decorin in
fibrollogenesis and has recently been reported to affect the viscoelastic properties of tendons as well
[49].
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Proteoglycans also sequester powerful signaling proteins such as fibroblast growth factor (FGF).
Degradation of the ground substance during injury and tissue turnover releases these growth factors to
stimulate ECM synthesis and cell growth.

Figure 2.9: Glycoproteins and protoeoglycans. (a) Glycoproteins are usually globular proteins with
branched oligosaccharide side-chains. (b) Shown here is a TEM darkfield image of many proteoglycans
linked to an axis of hyaluronan [50]. The core protein of this extremely large proteoglycan has hydrated
chondroitin sulfate and keratan sulfate side chains, and is attached to hyaluronan by link proteins.

3) Glyco-proteins are polypeptides with branched oligosaccharide (3-9 sugar) side chains. In
contrast with proteoglycans, their molecular weight is lower (50-100 kDa) [15] and the peptides
generally outnumber the sugars in proteoglycans. They are distinguished by how the oligosaccharide
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side chains are attached: O-glycosylation refers to bonding of the chain to the hydroxel group (OH) of
the peptides hydroxylysine, hydroxyproline, serine or threonine. N-glycosylation refers to bonding of the
saccharide chain to the N-terminus (NH2) of the peptide asparagine.
Multi-adhesive glycoproteins are large globular protein molecules including; fibronectin,
thrombospondin, tenascin-C and undulin. They are equipped with many binding sites for cells, platelets,
collagen fibers and other macro molecules, and can help cells anchor themselves within the ECM ground
substance [37,51].
Fibronectin is a multi-adhesive glycoprotein. It is secreted as a soluble inactive dimer of two
230–270 kDa monomers, each composed of a mixed chain of three repeating peptide sequences labeled
FNI, FNII and FNIII. Different combinations of these FN modules along the chain serve as binding sites for
cells, collagen, fibrin, and heparin and other macromolecules. Binding of fibronectin to the α5β1 integrin
on a cell’s surface changes the conformation of the fibronectin molecule to expose additional binding
sites, resulting in the further aggregation of additional cells and macromolecules together into an
insoluble matrix. Fibronectin is highly expressed in tissues undergoing remodeling repair, and fibrosis,
and has been called the “master organizer” by some investigators [37,51].

Figure 2.10: A) Fibronectin structure from N-terminus on left, with binding sites for cells, collagen, fibrin,
FN and heparin shown. B) The ribbon structures of FN modules types I, II and III drawn using PyMOL, this
illustrates the need for a conformational change to expose binding sites [51].
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Tenascin C is a 300 kDa glycoprotein that has a structural relationship to fibronectin but lacks its
adhesiveness to cells. Its level of expression is down-regulated in adults, but up-regulated in tissues
experiencing high tensile stress and during injury and repair. It is found of the blood of humans with
knee injuries and heart disease. It inhibits binding of fibronectin to its co-receptor syndecan-4 and
diminishes focal adhesions. It is hypothesized that this de-adhesive effect contributes to tissue
reorganization during repair.
Thrombospondins form a group of five modular glycoproteins TSP-1 to 5. TSP-1 (150 kDa) is
normally stored in platelets for release after injury, and has been shown to upregulate collagen I
expression during tissue repair. TSP- 2 is found bound to proteoglycans and cell membrane receptors. It
is also involved in collagen fibirllogenesis.
The relatively larger proteoglycan content in ligaments may be explained by their need for
greater extensibility in allowing certain joint motions. As an example the intra-articular cruciate
ligaments of sheep and rabbit knees have higher proteoglycan content than their respective extraarticular collateral ligaments. While tendons adapted more for skeletal positioning than energy return
are in the lower range of proteoglycan content.

Enthesis composition, morphology and function
The attachment site of a tendon, ligament or joint capsule into bone is known as an enthesis.
More than a simple insertion site, an enthesis must reduce the order of magnitude mismatch in moduli
of elasticity at the junction of two dissimilar materials, hard bone and tendon or ligament. Under
identical load a compliant soft tissue deforms much more than bone and this unequal strain along their
interface causes stress concentrations and even tearing [52].
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Two types of entheses have evolved to reduce stress concentrations. The first is the fibrous
enthesis originally termed an “indirect” enthesis by Woo [52]. This is because it typically occurs in the
appendicular skeleton where a tendon inserts tangentially along the diaphysis of a long bone. A subtype;
fibrous periosteal entheses, attach the tendon to the periosteal tissue that wraps around the entire
bone surface like a stocking. This spreads the tensile force that the tendon exerts over a wide area,
reducing the stress on the interface. Collagen fibers known as Sharpey’s fibers also penetrate from the
tendon through the periosteum into the lamellar bone providing further anchorage. A second subtype of
fibrous enthesis known as a fibrous boney enthesis occurs where the periosteum is lacking, here the
collagen fibers insert right into the bone without any intermediary periosteum. In time a fibrous
periosteal insertion can transform into a fibrous boney enthesis if the underlying periosteum is lost
through bone maturation [53].
The second type is the fibrocartilaginous enthesis originally referred to as the “direct” enthesis
because it typically occurs on the ends of long bones with the ligament or tendon making an almost
perpendicular insertion through the articular cartilage surface. Transmission electron microscopy of the
fibrocartilaginous enthesis by Cooper and Misol [54] has shown it can be divided into four zones; Zone
one just above the interface is of the tendon itself and consists of longitudinal collagen fiber bundles and
decorin. Zone two consists of fibrocartilage and of collagen types II and III along with proteoglycans
aggrecan and decorn. Zone three consists of mineralized fibrocartilage with type II collagen. And finally
zone four is bone with an interdigitated interface between itself and the mineralized fibrocartilage of
zone III [52,53,53,54].
This four zone morphology of the fibrocartilaginous enthesis reduces the mismatch in elastic
modulus by transferring the force over three separate interfaces of progressively increasing stiffness:
tendon/ligament - fibrocartilage; fibrocartilage - mineralized fibrocartilage; mineralized fibrocartilage -
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interdigitated with bone. This reduces the stress concentrations at each interface. The anterior and
posterior cruciate ligaments have fibrocartilaginous entheses at both ends [52–55].

Figure 2.11: Tendon enthesis. “The four zones of tissue at the tendon insertion to bone: Dense fibrous
connective tissue (CT), uncalcified fibrocartilage (UF), calcified fibrocartilage (CF), and bone (B). The
calcified and uncalcified fibrocartilage are separated by a tidemark (TM) that is straight and continuous
with a similar tidemark in the adjacent articular cartilage (AC)” [16].

Embryonic development of the fibrocartilaginous enthesis begins during endochondral
ossification when tendon/ligament attachments are made to the cartilage analog of the developing limb
bone. Cartilage under the early enthesis is eroded by endochondral ossification. The deeper area of
fibrocartilage is mineralized, and lamellar bone is deposited below. (See the following embryonic
development section).
In tendon, the progenitor cells for a fibrocartilaginous enthesis were originally believed to arise
from the growing mass of chondrocyte cells filling the bone template. However recent evidence from
cell lineage analysis indicates that these future enthesis cells attach to the bone template as a separate
module of cells expressing not only the Sox 9 transcription factor required for chondrocyte
differentiation, but also the Scleraxis transcription factor (Scx) associated with tendon cell
differentiation. Transforming growth factor Beta (TGFβ) signaling regulates the attachment of this
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module, and mineralization of its inner layer by endochondral ossification is initiated by Indian
hedgehog (Ihh) autocrine signaling along with parathyroid hormone-related protein (PTHrP) paracrine
signaling. The exact embryonic origin for this add-on module of cells is not yet known [3,56].
Tendon to bone healing after surgery has so far failed to recreate the native four zone fibrocartilaginous enthesis typical in the rotator cuff, distal patella tendon and also of the ACL. Rather, a
tendon graft heals to bone via formation of a fibrovascular scar tissue interface with material properties
inferior to the native enthesis. Remodeling brings Collagen fibers that grow transversely across the bone
tendon interface. This morphology is more typical of a “fibrous” enthesis such as at the distal medial
collateral ligament. In the fibrous enthesis the tendon/ligament enters bone outside of the joint
capsule, attaching tangentially along the shaft, with the interface reinforced with transverse collagen
fibers known as Sharpey’s fibers growing across the periosteum. [2]
Vascularity
Mature tendon and ligament are generally described as avascular in the literature, as can be
inferred from their pale appearance. Vascular supply comes from three locations: through the enthesis
(including both ends in ligaments), through the musculotendinous junction in tendons, and from vessels
running longitudinally along the peripheral layer known as the epitenon (or epiligament). The
epitenon/epiligament is the outermost layer that bundles the collagen fascicles together and is also
continuous with the endotenon membrane covering each individual fascicle. The peripheral blood
vessels take advantage of this continuity by passing anastomoses, transverse cross connections through
the endotenon to reach the interior [57].
Tendons making sharp bends such as the finger flexors are enclosed within a fibrous sheath to
guide them. Synovial fluid within this sheath provides lubrication for sliding and may also provide
nutrients to the tendon through diffusion. Diffusion through the synovial fluid may also supply nutrition
to tendons and ligaments within the intra-articular space [57].
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Embryonic development
During embryogenesis, all future tendon and ligament tissue originate from the lateral plate
mesoderm (LPM) [58]. Within the early embryo the mesoderm is one of the three primary germ layers
differentiating all cell and tissue lineage. Analogous to the cream filling of an Oreo cookie, the
mesoderm is sandwiched between the ectoderm and endoderm layers [59–61].
As a newly fertilized oocyte’s cells continue to divide and multiply forming a spherical blastocyst,
the germ layers begin as two flat plates of cells - the upper plate the epiblast, the lower plate the
hypoblast. Together they form the “bi-laminar disk” - an Oreo without the cream, dividing the blastocyst
into upper and lower hemispheres, each containing a fluid filled cavity; the amnion and yolk sack
respectively, for cellular nourishment [59–61].
By the end of the second week in humans, dividing cells in the epiblast - the dorsal layer, have
begun migrating to its centerline. This crowding of cells creates a ridge known as the primitive streak. A
greater proliferation of cells at one end of the streak forms the primitive node, marking its cephalic end.
Thus the embryo’s caudal-cranial axis and left-right sides are now defined, and the relative placement of
the future musculoskeletal features, including all tendons and ligaments can now proceed [59–61].
During the third week an invagination opens along the crest of the primitive streak as the
increasing proliferation of cells pushes them out the bottom of the streak to populate a third middle
layer, the cream in our Oreo cookie analogy - the mesoderm layer. Here these undifferentiated, mobile
cells loosely organize within a sparse collagen fiber matrix known as mesenchyme, the outer edges of
which are known as the lateral plate mesoderm (LPM) [59–61].
The blastocyst has just undergone gastrulation - the creation of all three germ layers. The
epiblast layer becomes the ectoderm; giving rise to outer body coverings, the nervous system, neural
crest and brain. Mesoderm cells go on to form the musculoskeletal, cardiovascular and urogenital
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systems. Additional mesoderm cells displace the hypoblast layer below to become the endoderm layer.
Endoderm cells become tightly packed, polar and columnar - to form the epithelial lining of the entire
gastro-intestinal tract, associated glands, and parts of the respiratory system [59–61].

Figure 2.12: Gastrulation of the blastocyst into the three primary germ layers
(http://staff.um.edu.mt/acus1/Gasrtrulation_files/image017.jpg)
Continued proliferation spreads the mesoderm (the Oreo cream) laterally between ectoderm
and endoderm layers, and by day 21 (in humans) its mesenchyme has formed into three regions of
decreasing thickness; paraxial, intermediate and LPM. Cells in the thick paraxial region group into a
columnar epithelial arrangements, forming balls of cells known as somites, arranged symmetrically into
pairs about the left and right sides of the notochord. This segmentation into somites proceeds rostral to
caudal (head to tail) creating up to 44 paired somites by day 30. Each somite will later segment into
groupings of undifferentiated cells known as dermatomes, myotomes, sclerotomes and syndetomes [62]
- the precursors of the dermal, muscular, axial skeleton and tendon respectively, at each vertebral level
along the spine [59–62].
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Secretion of sonic hedgehog (Shh) by the notochord signals cells in the nearby ventral-medial
portion of the somites to de-epithelialize and detach. These cells then surround the neural tube and
notochord, organizing into a mesenchymal matrix known as sclerotome, where they express the gene
Pax1. Out of the sclerotome, the cartilage, bone, tendon and ligament of the vertebrae and ribs will
arise, forming the axial skeleton. Leaving the neural tube to form the spinal cord and the notochord the
nucleus pulposus of the intervertebral discs [62,63].
Remaining cells on the dorsal side of the somites (known as the dermo-myotome) will split into
the dermatome and myotome, from which the dermis and skeletal muscle arise. Expression of myogenic
basic helix-loop-helix (bHLH) transcription factors Myf5 and Myor1 (formerly MyoD) drive cells from
each end of the dermatome to roll underneath it creating the myotome region. Back and axial muscle
precursors will emerge from the dorso-medial “epaxial” myotome. And appendicular (limb) muscle
precursors emerge from the ventral-lateral “hypaxial” myotome [62–64].
Signaling from within the myotome, possibly via FGF8, induces cells in the adjacent sclerotome
to express scleraxis. This Scx+ border strip segregates into a fourth somitic compartment of progenitor
cells, the syndetome, from which all axial tendons will arise. Its name comes from the Greek syndesis, to
bind and is ideally located between the two progenitor tissues it will eventually link, the myotome and
sclerotome [62].

Figure 2.13: Segmentation of the somites.
(http://www.mun.ca/biology/desmid/brian/BIOL3530/DEVO_05/ch05f29.jpg)
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Adjacent to the somites, the intermediate mesoderm will form the urogenital structures.
Further laterally, the thin LPM continues to spread out under proliferative pressure, splitting into two
layers: the visceral splanchnic layer that envelopes the gut tube, and the parietal (body wall) layer, from
which the cartilage, bone and, and the ligaments of the appendicular skeleton, will arise [59–61].
At two levels of the developing vertebral column, (the lower-cervical/upper-thoracic, and the
lumbar-sacral) increasing expression of several Hox genes drives proliferation of the parietal LPM to the
point where it bulges out bi-laterally underneath the ectoderm. These bulges are the developing limb
buds of the axial skeleton, consisting of a growing homogenous core of proliferating mesenchymal LPM
covered by a stretching outer layer of cuboidal ectoderm cells [59–61,65].
The distal edge of each limb bud flattens into a paddle shape (or flipper for lower limb) as
fibroblast growth factor (FGF) 10 expressed by the mesoderm cells induces the ectoderm cells at the
distal circumference of the paddle to form the apical ectodermal ridge (AER). Now expression of FGF-4
and FGF-8 by the AER cells feeds back, inducing continued proliferation of the mesoderm as
undifferentiated mesenchymal cells, growing the limb from proximal to distal [66].
A second signaling center, the zone of polarizing activity (ZPA) arises in the lower posterior of
the limb bud and engages in reciprocal signaling with the distal AER to polarize the anterior-posterior
axis (thumb to pinky) of the developing limb. Briefly, FGF from the AER induces the ZPA to produce
retinoic acid. Diffusion creates a posterior-anterior concentration gradient of retinoic acid through the
mesoderm cells, which affects the relative amount of sonic hedgehog (SHH) these cells express. The
resulting posterior-anterior gradient in SHH diminishes the amount of FGF produced along the AER,
affecting morphological changes from anterior to posterior in the developing limb [66]. (Figure 2.12) [67]
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Figure 2.12: Limb bud showing the apical ectodermal ridge responsible for initial signaling and the zone
of polarizing activity responsible for anterior-posterior digital patterning [67].

As the “progress zone” of proliferating mesoderm grows the limb bud in length, the more
proximal mesoderm cells, furthest from the influence of AER secreted FGF, soon condense into groups.
Local expression of the transcription factor Sox-9 causes these condensing cells to differentiate into
chondrocytes to follow the cartilage model of long bone development [59–61].
The new chondrocytes are wrapped together in a tube of perichondrium, a double layer
fibrocartilage sleeve that constrains their interstitial growth to follow the limb bud axis. Changes in
proximal-to-distal HOX gene expression pattern these cartilage cell condensations into templates for the
individual limb bones. For example, increased expression of HOX11A at the end of the humeral template
signals the beginning of the radius and ulna, while later expression of HOX12A, D signals the beginning
of the carpal bones of the hand [65]. (Figure 2.13)[67].

Figure 2.13: Changes in HOX gene expression signal changes in the cartilage analog [67].
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Ligament development
This change in HOX gene expression coincides with a local change in cell differentiation from

chondrocyte to fibroblast, creating a fibrocyte border between chondrocyte bone templates, and the
local expression of growth and differentiation factor 5 (Gdf-5) believed to mediate formation of articular
joint structure [68]. The center of the border will develop into a synovial cavity, with the adjacent
chondrocytes on either side forming articular cartilage. Condensations of fibroblasts within will bridge
this cavity and develop into both the ligaments and the synovial tissue lining of the new articular joint.
Evidence for the role of Gdf-5 in joint development can be found in mice Cruciate ligaments that tested
positive for Gdf-5 antibodies [69].
Concurrent with limb bud development, muscle precursor cells under the influence of
transcription factors Pax-3 and Pax-7 begin to delaminate from the hypaxialmyotomes of those somites
adjacent to the limb buds. Upon the induction of FGF and myostatin these cells are determined as
myogenic progenitors and migrate into the limb bud as dorsal (future extensor) and ventral (flexor)
muscle masses. With Myogenic regulatory factors Myf-5 and Myod1 expression (bHLH transcription
factors) they coalesce into muscle fibers and under myogenin they specify into extensor or flexor muscle
[62,64].
Tendon development is initiated by signaling from the ectoderm within a broad sub-ectodermal
layer above and below the developing cartilage model. This signaling induces cellular expression of
tendon specific markers such as follistatin and scleraxis - a basic helix-loop-helix (bHLH) transcription
factor essential for tendon differentiation. However the depth of tendon cell specification is limited by
BMP signaling from the interior mesenchyme which blocks scleraxis. Patterning of the tendon is aided by
a scaffold of mesenchymal lamina on both dorsal and ventral sides of the limb bud [64,69,70].
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Complex spatial and temporal changes in gene expression direct the morphogenesis of the
distal tendons, which develop apart from (and even without) their respective muscles, although the
maturation and segregation into individual tendons requires muscle cell migration into the limb bud. In
contrast the development of the proximal tendons is tightly coupled to that of the muscle precursors.
However the complex reciprocal signaling that directs the formation of the myotendinous junction and
the muscle/proximal tendon to its appropriate skeletal origin is still unknown [63,65,71].
Ridges and prominences on bones appear as the beginning of entheses, tendon insertion sites.
Originally the projections on the cartilage model, the developing entheses, were thought to consist of
cells separating out of the cartilage template, however recent cell linage tracing studies show evidence
that the entheses cells derive from an external pool of progenitors that are added on shortly after the
existing bone template is formed. These cells express both Sox9 and Scx and appear to arrive at the
attachment site as separate module from the chondro-progenitors within the bone template [3,56,72].
Like tendon cells, the enthesis progenitors co-express Sox-9 and scleraxis, setting them apart
from the chondrocyte fate which requires only Sox-9. If the enthesis does form as a separate module
which attaches to the bone analog, this could offer new opportunities for tendon and ligament
reconstruction. Could a stem cell patch, seeded with Sox9 and Scleraxis be anatomically placed to create
a new enthesis for a torn ligament or tendon?

Mechanism of Injury
Tendon and ligament injuries can be classified by their location and etiology. One of three
locations are reported: 1) through the mid-substance of the tendon/ligament, 2) at the enthesis, or 3) an
avulsion – a fracture through the bone below the enthesis, which can result in a detached tendon/or
ligament with a fragment of periosteum or enthesis still attached [73].
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The etiology can be immediate from trauma and acute overload or it occurs over time due to
the accumulation of micro and macro tears, with cellular repair efforts lagging. Unfortunately, the most
common cause of flexor tendon injuries is accidental laceration, often during work and food preparation
activities. Most acute ruptures of the strongest human tendon, the Achilles occur in fit men during
athletic activities, with biopsies showing evidence of chronic degeneration. This implies fatigue failure
from chronic degeneration reducing the tendon’s mechanical properties to the point where it fails
suddenly under a previously sustainable load. Rotator cuff tendon tears occur at the entheses on the
humeral head and are common in the aging, with over 50 % of those in their 80’s having a full thickness
tear. Here the etiology appears to be a combination of factors including accumulated micro trauma,
abrasion from under the acromion and age related degeneration [74].
The need for a strategy to prevent ACL rupture continues to drive research on understanding
the mechanism of this injury. Proposed theories include; excessive force of quadriceps contraction,
imbalance between hamstring and quadriceps forces, and even accumulated wear from abrasion by the
intercondylar notch of the femur on the ACL. Female athletes participating in pivoting and jumping
sports suffer a 2-8 fold greater rate of ACL injury than their male counterparts. This has generated
theories implicating excessive knee valgus on landing causing knee abduction moments, joint laxity from
hormonal effect, knee recurvation and reduced ACL size, to explain the increased rate in women [23].
Recent theories focus on impulsive compressive force generated on the knee joint during
landing, which results in a motion of the tibia similar to the clinicians pivot shift test for ACL laxity. Here
the resultant force and moment simultaneously pull the tibia forward while rotating it internally, thus
stretching the ACL past its ultimate strain. Implicated also in this theory is a flat footed landing that
reduces the ability of the calf muscles to absorb the ground reaction force and lessen its impulsive
impact on the knee [23,75].
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Native tendon and ligament healing process
Similar to dermal wound healing, healing in tendon and ligament consists of four sequential
phases; coagulation, inflammation, proliferation, and a lengthy repair/remodeling phase. Initiation of
the first phase requires bleeding – And while the tendon/ligament inner substance is an avascular
bundle of collagen fascicles, rupture of the capillary network in the epitenon, (epi-ligament) its outer
sheath, brings soluble blood proteins, normally shielded by endothelium, into contact with ECM collagen
fibers and glycol-proteins. This triggers a complex, yet rapid series of reactions resulting in blood
coagulation and inflammation. Progression through the subsequent healing phases requires release of
chemokines and cytokines by activated platelets and leukocytes to recruit the necessary phagocytic,
proliferative and remodeling cells from the surrounding vasculature and/or synovium [76–78].
Coagulation begins when platelets from the exuding blood coalesce at the wound site, their
numerous surface receptors and integrins bound to collagen fibrils and adhesive glycoproteins among
the exposed ECM, including, laminin, fibronectin, thrombospondin and von Willebrand’s factor. Ligation
of G-protein coupled surface receptors initiates an internal calcium mediated signaling path, stimulating
two enzymes, phospholipase C (PLC) and phosphatidylinositol 3-kinase (PI3k), activating the platelet.
[79,80] The platelet collagen receptor glycoprotein VI (GPVI), recognizes the repeated α-chain peptide
sequence glycine, proline, hydroxylproline (Gly-Pro-Hyp), while Integrin α2β1 has affinity for several
other collagen sequences including Gly-Phe-Hyp-Gly-Glu-Arg. Collagen ligation of GPVI alone is believed
sufficient for platelet activation, although whether concurrent ligation of integrin α2β1 is also required is
a matter of debate and ongoing research [79].
Activated platelets provide a catalytic surface (net negative charge with unsaturated acyl chains)
for the blood coagulation system to restore hemostasis. Exposure of tissue factor on the ECM to
circulating factor VII in blood initiates a cascade of reactions culminating in the conversion of
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prothrombin to thrombin by activated factor X. Thrombin now cleaves fibrin from inactive fibrinogen.
The resulting fibrin molecules readily bind together into fibers that crosslink into a reinforcing mesh
across the platelet aggregate. Ideally this fibrin reinforced coagulation will hold the torn tendon/
ligament fibrils together, facilitating repair by fibroblasts in the subsequent healing phases [79].
Coagulation however, must be regulated to prevent downstream ischemia. With negative feedback,
tissue factor pathway inhibiter (TFPI), a protease inhibitor slows factor Xa’s conversion of prothrombin
[81]. Plasmin, cleaved by thrombin from plasminogen, must eventually dissolve the fibrin coagulation
and restore circulation, once the vessel endothelium is repaired [82].
Activated platelets release a burst of chemokines and pro-inflammatory cytokines from internal
α, δ and λ granules. Platelet α granules contain a large number (>280) of bio-active proteins including
growth factors necessary to drive the proliferative and remodeling phases including; platelet derived
growth factor (PDGF), transforming growth factor β (TGF-β) and fibroblast growth factor (FGF). Granule
release of additional VWF and fibronectin amplifies the clotting cascade and furthers platelet
aggregation. Recent evidence indicates that differential release of granules by platelets can selectively
modify the wound site environment and regulate healing [80].

Inflammation begins with a loss of integrity between the normally tight junctions of blood vessel
endothelial cells, allowing an efflux of cells and plasma proteins into an injured tissue to promote its
repair. One inflammatory pathway occurs when circulating prekallikrien adheres to a negatively charged
surface (platelet) facilitating activation by factor XII. Activated kallikrien cleaves high molecular weight
kininogen, freeing bradykinin. Ligation of bradykinin to the B2 receptors on endothelial cells then
activates their vasodilation [83]. Chemokine interleukin 8 (IL-8) attracts an influx of polymorphonuclear
cells, or neutrophils (PMNs) from the surrounding blood vessels and synovium. These immune cells
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begin by removing pathogens and wound debris by phagocytosis. PMNs arrive soon after platelet
degranulation, and reach a peak number early – as early as one day post injury in aseptically transected
rat MCLs [78], provided there is no bacterial infection.
Tissue damage can trigger activation of the complement cascade, a system of circulating innate
immune system proteins resulting in the release of potent chemoattractants, anaphylatoxins C3a and
C5a that recruit circulating monocytes to the wound bed where cytokines promote their differentiation
into mature tissue macrophages. These circulation derived monocytes/macrophages are identified by
their expression of antigen ED1 and are catabolic and phagocytic, clearing the wound bed of debris,
pathogens and apoptotic PMNs. A separate population of antigen ED2 + resident macrophages does not
participate in phagocytosis and is believed to have an anabolic role, stimulating cell mitosis and down
regulating `inflammation during the proliferation and remodeling phase. These resident ED2 +
macrophages reside primarily in the epiligament/epitnon.
Macrophages follow PMNs and soon become the dominant immune cell type. One rat study
showed a peak population of both ED1 and ED2 types by day 5 after MCL transection in the rat.
Compared with a rat ACL-R study showing an absence of ED2 macrophages until day 11 postop, peaking
from day 14 to 28 reflecting time to migrate into the graft. Within several days after injury, tissue
macrophages have become the dominant cell type within the wound bed, and continue clearing it of
debris, pathogens and early arriving apoptotic PMNs by phagocytosis. Macrophages also produce
protease and metalloprotinase enzymes that facilitate the wound debridement process by cleaving
damaged collagen fibrils.
The presence of T-lymphocytes attracted by interleukin 1 (IL-1) marks the late inflammatory
phase and the transition to the proliferative phase. Now macrophages release TGF-β, PDGF and vascular
endothelial growth factor (VEGF), attracting an influx of fibroblasts into the wound bed. While the
fibroblasts fill the voids left from debridement by randomly extruding collagen fibrils and fibronectin,
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VEGF prompts the infiltration of endothelial cells which form a capillary network to support this new
granulation tissue.
The fourth, remodeling phase involves removal of the poor quality granulation tissue and its
replacement and realignment along the lines of tensile stress with an organized matrix that approaches
the mechanical properties of the original tissue [77].
Ligaments such as the medial collateral ligament (MCL) of the knee follow the above four phase
process and are treated conservatively by clinicians, typically healing with rest and without the need for
further intervention. This is because the MCL runs outside of the joint capsule for most of its length and
has an ample blood supply from both surrounding tissues and its vascular tendon sheath, facilitating the
arrival of platelets and the formation of a fibrin clot to hold the torn MCL ends together. The clot serves
as a scaffold both for neovascularization to support the three phase healing process and for fibroblast
cells to cross and lay down collagen fibers that restore the original matrix and its directional orientation
[84].
Unfortunately the prognosis for the anterior cruciate ligament (ACL) is much poorer. Murray et
al. examined 23 completely ruptured human ACL specimens recovered over a wide range of from ten
days to three years after initial rupture when the patients underwent open knee surgery. Their study
provides a unique histological documentation of all phases of the human ACL healing process. (Murray
2000).
The histology of those ACL specimens recovered up to three weeks post rupture appeared
consistent with the inflammatory phase of healing. Staining of specimens revealed concentrations of
immune cells around damaged capillaries near the break including neutrophils, lymphocytes and
macrophages actively phagocytosing debris. Some clotting was seen on individual ACL remnants but
never any bridging connection unifying both ends, instead the ACL remnants appeared swollen with torn
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friable ends resembling “mop ends”. Blood vessel density increased to a mean of 4 vessels / mm
compared to intact control ACLs with 1.5 vessels / mm. Cell density had decreased slightly to a mean of
614 cells /mm compared with 701 /mm in controls.
Specimens from three to eight weeks post rupture showed a gradual overgrowth of synovial
tissue covering the ligament remnants, eventually encapsulating them and giving them a mushroom like
appearance. No evidence of any clotting or granulation tissue bridging the torn ACL remnants, nor any
vascular proliferation had occurred. Clearly the second proliferative phase of healing had not begun.
Murray coined the term “epiligamentous repair period” to describe this three to eight week
encapsulation period specific to ACL healing. Within the synovial sheath growing over the ligament
remnants, fibroblast proliferation and blood vessel density necessarily increased, with an abundance of
these fibroblasts expressing α-smooth muscle actin, a protein with contractile properties.
Specimens from eight to twenty weeks after rupture was showed increasing blood vessel
density and cell proliferation within the remnants characteristic of the proliferative healing phase,
reaching a peak cell density of 2,244 /mm between 16 and 20 weeks. Most were fibroblasts arranged
without any particular alignment to the ligament axis. The epiblast layer now completely covered both
proximal and distal remnants and merged with the synovial capsule.
In ACL specimens from one to two years after rupture, the ligament ends remained separated,
although remodeling had begun. Fibroblasts and collagen fascicles were now more aligned with the
ligament remnant axis. Both blood vessel density and cell density had decreased from their maximum
achieved between 16 – 20 weeks post rupture. The synovial tissue sheath over the remnants persisted
but decreased in thickness. Clearly a healed functional ACL had not reformed.
The failure of a provisional scaffold to form bridging the two mop ends together; a necessary
requirement for cells to invade and begin the proliferative and remodeling phases as in extra-articular
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ligaments like the MCL, is likely due to the serine protease plasmin that rapidly degrades fibrin. Its
precursor plasminogen, is present in the synovial fluid of the knee joint and is activated by a urokinase
plasminogen activator produced by synovial cells after an injury. This prevents any coagulation from
forming within the intra-articular environment that could restrict joint movement [82].

Early attempts at primary repair of the ACL
In 1972 before the advent of arthroscopic surgery, surgeons Feagin and Curl began studying ACL
ruptures in 64 West Point Cadets [85,86]. All had undergone arthrotomy, visual verification of the ACL
tear and an open primary repair. Each tear was at the proximal end of the ACL (at the femoral enthesis).
Primary repair here meant a suture only repair, which consisted of a figure 8 stitch in the tendon to
avoid pull out. The ends of the suture pulled through one or two holes drilled into the lateral femoral
condyle, securing the severed end of the ligament back onto the femoral enthesis from which it had
ruptured (Figure: 8). In their 1975 follow up study, Feagin and Curl [85,86] reported that of the 32
interviewed, 24 reported impaired athletic ability, and 12 required additional surgery. The second
surgery revealed 6 with ACLs that were so lax that they were judged incompetent, two that were retorn, and only 4 with adequate function. Further follow-up of these same cadets in 2009 revealed that
greater than 50% reported impaired function in their repaired knees [86].
As a result of these and other studies, attempts at primary repair have been abandoned, in favor
of complete ligament reconstruction, as this quote from Taylor et al eloquently states: “In the 30 years
since the first West Point reports, ACL tears have become a well-recognized orthopedic injury. Surgical
treatment has evolved from the initial attempts at primary repair to reconstructions that are now one of
the most commonly performed orthopedic operations” [86].
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ACL Reconstruction Procedure
The decision to undergo ACL reconstruction rests on the patient who must weigh managing
recurrent knee instability, possibly with meniscal tearing and accelerated knee arthrosis, against the
time lost undergoing ACL-reconstruction with 6 to 12 months of rehabilitation (along with the possibility
of a failed repair). Reconstruction is recommended for athletes returning to play and most active
patients opt to go ahead with it.
Currently most ACL reconstruction procedures are performed arthroscopically and consist of a
tendon graft to replace the torn ACL that is pulled through a tunnel drilled in the anterior tibia, exits on
the tibial plateau, crosses the joint space and terminates in a femoral socket drilled within the lateral
side of the intercondylar notch. The goal is to place the tunnel exit and socket entrance within the
footprints of the native tibial enthesis and femoral enthesis, respectively, with the graft appropriately
pre-tensioned and anchored with interference screws, to approximate the anatomic position and
function of the native ACL.
The decisions made on operative procedure, type of the tendon graft used and its source,
autograft or allograft from a donor, are all currently controversial, each having pros and cons, with no
clear evidence for the superiority of any one over another in the literature, with the final choice often
depending more on the training, ability and experience of the surgeon.
Quadrupled hamstring, quadriceps tendon or bone-patella tendon-bone (BPTB) are commonly
used for tendon autografts. The later BPTB, is harvested with bone blocks at each end, giving it the
advantage of a friction fit into the femoral and tibial bone tunnels (with interference screws) and is
recommended for athletes and those desiring a quick return to activity, in the hope that it will reduce
graft slippage and prevent developing knee laxity. Autografts are free of concerns for disease
transmission and immunologic rejection. Although they do result in longer operations, additional
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harvest site wounds and are associated with increased risk for impaired flexion/extension function in
the source muscle, and with increased donor site morbidity, particularly after the patellar bone block
harvest for a BPTB graft.
Allografts are used in revision ACL-r when it is desirable to avoid harvesting from the
contralateral limb, and in patients requiring a less demanding postoperative rehabilitation.
Disadvantages of allografts include the possibility of immunological rejection, arthrofibrosis and higher
costs for sterilization and storage. Sterilization is of necessity required for allografts, and unfortunately
degrades the graft mechanical properties and is associated with higher failure rates.
An established ACL-r procedure is the transtibial (TT) technique where a portal is made and the
tibial tunnel is drilled first. The drill then continues through the tibial tunnel into the joint-space and
drills the femoral socket, without requiring an additional portal. Criticism of this technique comes from
its tendency to position the femoral socket too high in the intercondylar notch, resulting in a nonanatomic vertically oriented graft that cannot constrain internal knee rotation [87]. An alternative
technique is the anterior-medial portal (AMP) that requires an additional portal and increased knee
flexion to drill the femoral socket within the native enthesis footprint. Proponents claim it results in a
more obliquely oriented and anatomically correct graft [88]. A third technique known as the double
bundle or double socket technique uses a doubled graft to replicate the distinct anterior-medial and
posterior lateral fascicle bundles of the native ACL, where the anterior medial bundle resists anterior
tibial translation, and the posterior lateral bundle resists tibial rotation [89]. Unfortunately a metaanalysis has failed to show the superiority of one technique over another [87].
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Effect of Rehabilitation
No standardized rehabilitation program for ACL reconstruction exists and protocols vary among
practitioners and institutions. Yet rehabilitation is essential to regain the muscle strength and knee
range of motion (ROM) commonly lost with ACL rupture [14]. Unfortunately, surgical ACL-R brings
additional swelling and effusion that further contribute to reduced ROM and muscle strength.
No universally effective method has been found to restore full pre-injury strength, and the
muscle weakness associated with ACL injury persists with many patients having quadriceps muscle
strength deficits in excess of 20 % after 6 months of rehabilitation. Strength differences between the
injured and un-involved leg can persist for years afterward and contribute to knee instability and early
arthritis [90,91].
A reduced ability to voluntarily activate the quadriceps muscle known as arthrogenic muscle
inhibition (AMI), along with already diminished strength, retards the progress of rehabilitation exercise.
Diminished proprioception, the positional awareness lost with the stretch sensitive nerves within the
original ruptured ACL, is a proposed etiology for AMI [90]. Unfortunately, since the quadriceps maintains
dynamic knee stability through co-contraction with the posterior thigh muscles (hamstrings), any
weakness or delayed activation places further strain on the healing tendon graft ACL-R. Weakened
quadriceps and hamstring muscle groups leave the vulnerable ACL-R as the only taught tether
restraining a femur sliding on the tibial plateau with the weight of the body above.
During the early postoperative weeks, the healing tendon graft ACL-R is secured only by
interference screws or other fixation devices and can be dislodged if overstrained, therefore the patient
must be guided through exercises that incrementally progress in ROM and intensity [14]. To protect it
many surgeons prescribe a knee brace to be locked at or near full extension for walking and activities of
daily living (ADL). However many studies show that brace use has little effect on long term knee stability,
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and may even contribute to disuse muscle atrophy [92]. If additional repairs are performed during the
same operation, longer term brace wear from four to eight weeks may be prescribed. These include;
meniscal repairs, articular cartilage repair procedures including micro-fracture and OATS, an “over the
top” ACL-R performed in skeletally immature youth (with a non-calcified growth plate), or a concomitant
MCL injury that could further destabilize the knee [90,93].
ACL rehabilitation has evolved historically along with ACL-R techniques, often without objective
evidence to support the protocols. In the 1970’s prior to the advent of arthroscopy, arthrotomies were
made to access the knee joint and attempt either a sutured primary repair or primitive reconstruction.
Afterwards the leg was placed in a plaster cast for up to 6 weeks of immobilization [85]. The practice of
casting continued until it was observed surprisingly, that noncompliant patients who resumed activity
early had superior functional results [94].
Quadriceps strengthening exercises were downplayed during the 1970-80’s to protect the graft
from overstrain. In their place the use of Continuous Passive Motion (CPM) machines was copied from
total knee arthroplasty practice to cyclically flex the knee without muscular activation. These have now
been largely abandoned in favor of active motion exercises that help maintain muscle strength. Patients
were not cleared for return to sports until the subjective criterion of six months post operation had
passed [94].
A 1987 study hypothesized that early resumption of passive knee motion after ACL-R would not
increase swelling and effusion. By week three a group that had begun CPM early on post-op day two lost
an average of only 2 -3.5 cm of thigh girth. This compared favorably to a group which started CPM later
on day seven and lost an average of 6.5 cm girth. However since the ACL-R in the early group was
performed arthroscopically while the ACL-R in the late group was via an arthrotomy, it is difficult to say
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whether time of onset or invasiveness of operative method more responsible in preserving thigh girth,
although the authors vigorously advocated for an early resumption of motion in the conclusion [95].
A common goal of 6 months to return to sports activity is often given, although it can take as
long as a year, the actual duration depends more on the patient’s compliance and achievement of
performance milestones before advancing to the next phase of the protocol. Before clearance to return
to any sport with pivoting, cutting and jumping activities the patient must demonstrate safe functional
ability [94]. A generic protocol typically consists of one preoperative phase to reduce pain and swelling
and four postoperative phases [14,92–94,96,97]:
Phase 0, Preoperative: Begins as soon as possible after injury. Object is to reduce pain and
swelling and maintain ROM and forestall muscle atrophy.
Phase 1 Postoperative (Day 0 to 4 weeks): Begins on the gurney after ACL-R surgery with
isometric quadriceps contractions and ankle pumps. Goals are to resolve postoperative swelling, regain
full knee extension and up to 90° to 125 of flexion (depending on program), and restore ability to control
the leg while weight bearing, all while protecting the tendon graft from overstrain.
Neuromuscular electrical stimulation may be added to increase quadriceps contraction during
active motion exercises. Some programs end crutch use during the first week if gait is normalized with
brace on, and end brace use soon after.
Phase 2 (weeks 5 – 11) Goals: Increase knee, hip and ankle strength, improve balance and
proprioception. Regain full ROM at a pace of 15⁰ per week. Less aggressive protocols aim to end crutch
use by week six. By the eight week closed chain exercises including full squats and lunges are added to
improve eccentric quadriceps and eccentric hip abductor strength.
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Phase 3 (12 – 16 weeks): Goals regain 85 % of the strength of, and reduce dependence on the
non-operative leg. Develop eccentric muscle control to enable impact activities such as jogging. Before
progressing to phase four the patient must be able to land from a hop showing good eccentric hip
abductor control, quadriceps control and external rotation control.
Phase 4 (4 - 6 months): The overall goal is to return to pre-injury level of play or activity. The
patient must develop neuromuscular control for rapid change of direction and quick stop movements.
Criteria for return to play are; demonstration of single leg impact control, full ROM, 85% of the
strength of the noninvolved leg, less than 15% deficit in hamstring - quadriceps strength ratio and no
pain or swelling.
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Thesis Outline and Hypothesis Formulation
An essential goal of this chapter was to emphasize the complexity of tendon/ligament healing, a
process of four sequential phases, each a prerequisite for the next and requiring temporal recruitment
of specific cell types for completion. While connective tissues with adequate blood supply such as the
Achilles tendon and the collateral ligaments normally heal through conservative management, tendon
and ligament tears occurring within the synovial joint capsule often fail to heal due to dissolution of the
initial coagulation, effectively preempting subsequent phases of the healing process.
A complete ACL rupture is a common and debilitating example of this failure to heal in the
synovial environment. The gold standard for its care being surgical reconstruction via a tendon graft
through bone tunnels, followed by a lengthy rehabilitation period at a large personal and societal cost,
with over 120,000 per year in the US.
Clinical Problem
Immediately following ligament reconstruction the surgeon is faced with a dilemma, will the
prescribed rehabilitation protocol adversely affect the healing tendon graft? A recent clinical trial of
early aggressive ACL-R rehabilitation showed radiological evidence of bone tunnel widening [98]. Will
the repeated tensile loading imposed during passive or active knee motion cause creeping elongation of
the tendon graft? Increased knee laxity from either cause could result in failure of the reconstruction.
Yet active muscle contraction must begin immediately, preferably on postoperative day one, if
the atrophic process is to be reversed, and the patient is to reacquire sufficient proprioception
governing effective co-contraction of quadriceps and hamstring muscles, essential to stabilizing the knee
joint. Otherwise the vulnerable tendon graft, secured primarily by interference screws (prior to bone
tunnel ingrowth and remodeling), will be the sole restraint to relative tibial-femoral motion.

48

Ideally, to prescribe an optimum time point to initiate postoperative rehabilitation after ACL-R,
the surgeon must balance the need for stress shielding allowing tendon graft to bone healing, with the
active knee motion needed to retain/regain muscle strength and coordination. However little objective
evidence exists to guide this prescription, and the time-point when tensile load ceases to be an obstacle
to healing and instead a promotor of bone tunnel ingrowth and graft homeostasis remains unknown.
The long term goals of our research group are to better understand the intrinsic cellular and
extrinsic mechanical factors that govern tendon to bone healing and to develop methods to recapitulate
the native enthesis whether fibrous or fibrocartilagenous, in surgically repaired tendons and ligaments.
The objective of this thesis is to identify the optimum time-point to initiate postoperative knee motion
in a rat model of ACL_R. To do this we will test the following hypotheses:
H0, we predict that immediately following ACL_R; cycles of tensile load on the tendon graft, applied daily
for two to four weeks, will impair tendon graft to bone tunnel healing, compared with continuous
postoperative load shielding of the graft for two to four weeks, as evidenced by changes in bone tunnel
volume, cell populations and tensile strength of the ACL_R.
H1, we predict that immediately following ACL_R; a load shielding period of 4 to 10 days, prior to the
imposition of daily tensile graft loading, ending on postoperative day 14 or 28, will improve tendon graft
to bone healing, compared to both immediate onset daily graft loading, and continuous load shielding.
Rational: We formulated these hypotheses based on our preliminary data showing a gradual, sequential
infiltration of immune cell types into a transplanted tendon graft [10], entering first the new granulation
tissue between tendon and bone tunnel wall. While populations of neutrophils engaged primarily in
phagocytosis peaked by day four, those cells with a role in remodeling, such as ED2 antigen positive
macrophages – believed capable of osteoclast differentiation, did not appear in the inner tendon graft
until day 14, coinciding with peak vascular ingrowth. We posited that delaying rehabilitative motion until
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these cells began repopulating the graft would have the most beneficial anabolic effects, while
immediate motion would create a continuous influx of inflammatory cell types, with secretion of
catabolic cytokines such as IL-1 and TNF-α, and production of metalloproteinases which while useful for
debridement, would degrade and weaken the tendon graft.
Significance: May provide basis to contradict clinical trend toward immediate post-op mobilization.
Improved rehabilitation protocols that improve the strength of ACL_Rs may help reduce the reportedly
higher rates of failed reconstruction in young highly active patients.
Aim 1: Design a device to exert controlled tensile strains on a tendon graft healing into bone tunnels, in
a rat model of ACL_R. Additionally, the device must also shield the tendon graft from strains induced by
knee joint motion between experimental sessions.

(Completion of aim 1 is detailed in chapter 3.)

Aim 2: Determine the effect of cyclic tensile load on tendon to bone healing. We applied protocols of
either; a daily session of cyclic tensile strain, or continuous knee immobilization, to subjects on
postoperative day one after receiving ACL_R, with durations of either 2 or 4 weeks. Healing was
assessed through analysis of immune cell influx, bone tunnel ingrowth, mineral content, angiogenesis
and failure load of the femur-tendon-tibia construct.
Aim 3: Determine the effect of varied immobilization periods prior to cyclic tensile loading, on tendon to
bone healing. Post ACL_R we randomly assigned groups to four and ten day immobilization periods
before beginning a daily protocol of cyclic tensile strain. Subject groups were sacrificed at either two or
four weeks post ACL_R. Healing was assessed through analysis of immune cell influx, bone tunnel
ingrowth, mineral content, angiogenesis and failure load of the femur-tendon-tibia construct.
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Chapter Three:
A Novel In Vivo Joint Loading System to Investigate the Effect of Daily Mechanical Load on a
Healing Anterior Cruciate Ligament Reconstruction.

Preface
Chapter three details fulfillment of the specific aim upon which all subsequent data collection
depended, and was a published article in the ASME Journal of Medical Devices. It required a device to
exert controlled tensile strains on a tendon graft healing into bone tunnels, modeling the effect of daily
ACL-R rehabilitative sessions on the graft. Between experimental sessions the device was also required
to function as a strain shield by blocking knee flexion and rotation.
To continue use of our established rat model of ACL-R, the most viable method for strain
shielding the graft was via external mechanical knee fixation. Although the ACL experiences all strains;
tensile, compressive and torsional, we decided to limit our model to uniaxial tension to simplify data
collection and any future mathematical modeling. This decision required design of a complex external
fixator to maintain the femoral and tibial bone tunnels in coaxial alignment, with the additional
requirement that it split in two during experimental sessions, allowing its tibial half to be translated
distally while constrained parallel to the tunnel axis, thus achieving uniaxial graft strain.
The methods section details design of this external fixator and its use with custom jigs during
ACL_R surgery to facilitate coaxial drilling of the femoral and tibial bone tunnels (Figure 3.2).
Unfortunately the thin 0.9 mm diameter threaded pins used to attach the fixator halves to the femur
and tibia exhibited excessive bending under load, reducing both the stepper motor applied distraction of
the joint space and the effective graft strain.
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This called for an extensive characterization of mechanical compliance explained in section 3.1.
Here optical tracking of reflective makers across the joint space measured the true knee joint distraction
while load was applied through the fixator, in eight rat cadaver specimens of ACL_R. From each of the
eight optically recorded displacement versus load relations, the original LVDT measured displacementload relation was subtracted giving the total system compliance for each specimen. All eight tests
exhibited a linear deformation characteristics, therefore a least squares approximation of 41.3 μm/N
was calculated to use as a correction factor in the subsequent experiments.

Abstract
We designed and validated a novel knee joint fixation/distraction system to study tendon to bone
healing in an in vivo rat model of anterior cruciate ligament (ACL) reconstruction. The system uses an
external fixator to apply a cyclic distraction of the knee joint while monitoring the resultant force
developed across the joint space, thus providing a temporal indication of structural changes during the
healing process of the bone-tendon-bone reconstruction. Validation was performed using an optical
kinematic tracking system to determine the local displacement of the knee. Average system compliance
was determined to be 42.4 ± 8.8 µm/N with a coefficient of variation of 20.7%. The compliance was used
to obtain a best fit correction factor which brought the total root mean square error of knee joint
distraction to within 179 µm (16.1%) of the applied distraction. We performed a pilot study using 15 rats
that had ACL reconstructions using a flexor digitorum longus tendon autograft and found that the animals
tolerated the indwelling fixator and daily anesthesia over a 10 day loading protocol. Our knee joint
fixation/distraction system provides a valuable tool to study how mechanical stimuli affect in-vivo bonetendon-bone healing.

52

Introduction
A traumatic rupture of the anterior cruciate ligament (ACL) of the knee is a common athletic injury
with as many as 100,000 occurring each year in the United States [99]. Loss of ACL function results in knee
instability with the potential for further knee damage, and may predispose the individual to the early
onset of osteoarthritis. Surgical treatment consists of ligament reconstruction using a tendon graft, placed
in bone tunnels drilled into the femur and tibia, approximating the position of the native ACL and reestablishing its constraining link (Figure 3.1). This procedure requires secure tendon to bone healing to be
successful [86].
The resumption of mechanical load on the reconstructed ACL normally begins during postoperative
rehabilitation. Typically this rehabilitation involves some degree of passive and active joint motion, while
avoiding excessive loading of the tendon graft as it heals to the bone. This joint motion places the tendon
graft in tension, and produces shear stress at the tendon to bone tunnel interface [2]. Although it is well
established that tensile strain has a positive effect on tendon and ligament physiology, its effect on the
healing tendon-bone or ligament-bone junction is poorly understood. As a result, there is little consensus
on the optimum time of onset of post-operative rehabilitation and the subsequent mechanical loading of
the ligament graft [100,101].
The insertion site or enthesis of the native ACL is a highly specialized tissue consisting of a progression
through four distinct zones: ligament, fibrocartilage, mineralized fibrocartilage, and bone, that serves to
resist stress concentrations and securely anchor the ligament to bone [54,102]. Mechanical loading is
thought to play a role in the post-natal development of these four zones [103,104]. Animal models of
ligament reconstruction via tendon graft demonstrate that the four zone morphology and composition of
the native enthesis is not restored during the healing process. Rather, a tendon graft heals to bone via
formation of a fibrovascular scar tissue interface, with material properties inferior to the native enthesis
[2,16].
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Our long-term goal is to study the effects of mechanical loading on the healing tendon-to-bone tunnel
interface, and hopefully identify a mechanical load regime and time of application for optimal
rehabilitation of post-surgical ACL reconstruction. We developed a novel mechanical system using a
previously developed rat model of ACL reconstruction [105,106]. A custom designed external joint fixation
device (ex-fix) is surgically placed during ACL reconstruction on the femur and tibia of each animal. This
ex-fix is interfaced to our mechanical loading system to apply controlled cycles of distraction to the
reconstructed knee joint, reproducing the relative graft motion of the tendon in the bone tunnel, or
interface shear described above. Our novel system allows for repetitive, controlled loading of a healing
tendon graft reconstruction an in-vivo animal model.
To effectively allow comparison of subject groups undergoing different loading protocols and to
measure temporal changes in force as a function of joint distraction during healing, the system was
designed to satisfy the following requirements:
1. Allow for cyclic distraction of the knee joint space in an anesthetized animal that has undergone
ACL reconstruction using a tendon graft placed in bone tunnels in the femur and tibia.
2. Allow the experimenter to vary the amount of distraction and number of cycles.
3. Record the force generated across the knee joint space as a function of distraction, for each
cycle, of each loading session.
4. Constrain knee joint motion between loading sessions to eliminate or minimize uncontrolled
distraction during cage activity.
5. Avoid undue discomfort and allow normal cage activity and feeding.
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Figure 3.1: Illustration of an ACL reconstruction using a tendon graft pulled through drilled bone tunnels
in the femur and tibia. The graft is secured with sutures to the periosteum at the tunnel exits, outside of
the joint.
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Methods
System Overview. The system consists of two components: a metal, external fixator that spans the
knee of each animal and a motorized Cyclic Distraction Mechanism (CDM). During daily loading sessions
the ex-fix is attached to the CDM. The bar linking femoral and tibial parts of the ex-fix is removed, and
controlled cyclic distraction of the knee joint is performed by the CDM, resulting in a cyclic elongation of
the healing tendon graft.

Figure 3.2: Illustration of ex-fix placement immediately before ACL reconstruction.
Mounting jigs are temporarily supported on the bone tunnel drill bit. These jigs hold the ex-fix parallel to
the tunnel axes, while two pins each, (0.9mm threaded k-wires) are drilled into the femur and tibia.
After the ex-fix pin clamps are tightened down onto these pins, the drill bit and mounting jigs are
removed. The graft tendon can now be pulled through the tunnels and secured with sutures to the
periosteum at the tunnel exits, completing the ACL reconstruction.
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Fixator Design.
The ex-fix provides for the controlled distraction of the knee joint and the elimination or
minimization of knee motion when locked with a rigid bar between loading sessions (Figure 3.2). It consists
of identical femoral and tibial “pin-clamps”, suspended by universal joints from the removable locking
bar. The universal joints allow positioning of each pin-clamp so its jaws can be tightened onto two
threaded 0.9 mm diameter pins (MicroAire 1600-635T Surgical Instruments, Charlottesville, VA) drilled
into each bone, securing the ex-fix to the animal. This pin diameter was the maximum allowable without
inducing an unacceptable incidence of fractures. After final adjustment, the screws on the universal joints
and pin-clamps are tightened to maintain their relative orientation.
Initial prototypes of the ex-fix demonstrated excessive compliance caused by cantilever bending of
the 0.9 mm diameter pins, which limited knee distraction. As a remedy a bilateral support of one pin from
each bone was implemented (Figure 3.3). Tubular clamps supported from the CDM secured the free end
of the threaded pin protruding through the skin on the medial side of the limb. This reduced pin deflection
and compliance of the ex-fix to an acceptable amount relative to the distraction distance, as shown in the
results.
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Figure 3.3: Anesthetized rat during loading in the CDM with bilateral support of bone pins.
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Cyclic Distraction Mechanism.
The CDM used a linear bearing (Nippon Bearing No. SEBS 12A2-145, Wood Dale, IL) consisting of
two roller bearing blocks riding on a rigid linear rail (Fig.3). A stepper motor driven linear actuator (Oriel
No. 18503 via Oriel controller No 20010, Oriel Corp., Stratford, CT. Accuracy: ± 5 μm, repeatability < 2 μm)
moves one block while the other is held stationary by a load cell (Transducer Techniques MDB-5,
Temecula, CA. nonlinearity < 0.05 % of rated output, nonrepeatability < 0.05 % of rated output) fixed to
the frame of the CDM. A linear variable differential transformer (LVDT), measures the displacement of the
moving block (Schaevitz LBB315 PA-100, Measurement Specialties, Inc., Hampton, VA. linearity < ±0.20 %
of full range output, repeatability 0.10 μm).
During animal loading, the ex-fix is attached to the linear bearing with its femoral part secured to the
stationary block and the tibial part secured to the motor-driven block. The ex-fix locking bar is removed
to allow the actuator to displace the tibia from the femur. The load cell simultaneously reads the force
developed through all soft tissues across the distracted joint space, including the graft tendon.
A custom program was developed in LabVIEW (National Instruments, Austin, TX) to control the CDM
and record the load-distraction data. The program operated in closed loop mode and used displacement
feedback from the LVDT to control the position of the stepper motor actuator. The force/distraction data
were recorded to a file through a data acquisition card (No. 6036E, National Instruments, Austin, TX). The
control program also provided for continuous correction of the displacement due to the mechanical
compliance of the system.
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Characterization of the System
Compliance. We determined the compliance of the entire system (CDM with ex-fix), rather than
listing the specifications of its individual components, keeping in mind that mechanical stimulation of the
graft depends on the accuracy and repeatability of joint space distraction. We also characterized the
variability in the compliance, since numerous intra-operative factors may affect system compliance
between animals.
System compliance was calculated indirectly in five animals with bilateral fixation in vitro by taking
the difference between the displacement-load response of the ACL-reconstructed knee and the
displacement-load response of the knee and system. The linear slope of the resulting displacement-load
curve represented the compliance of the system alone. Displacement of the knee joint was measured by
a kinematic tracking system as described in the section below (Measurement of Knee Distraction), while
displacement of the knee and system was measured by the LVDT mounted on the CDM.
System compliance was also directly measured in three animals with bilateral fixation in vitro by
securing a 1.2 mm diameter metal wire across the knee joint. After the wire became taught, it allowed no
further distraction of the knee joint; therefore, the resulting joint distraction curve reflected deformation
in the system. Slope of the linear portion of the displacement-load curve represented the compliance.
In both experiments, device compliance was calculated using the data from the sixth loading cycle.
Maximum load for these experiments was limited to 39.2 N (4000 g) because higher levels caused
increased incidence of bone fracture.
We also indirectly characterized the compliance of the system with unilateral fixation. This provided
a basis for comparing the effect of adding bilateral support of the bones on compliance. The
characterization was conducted using ten animals in vitro. Maximum load in these experiments was

60

limited to 12 N to ensure that the excursion range of our stepper motor or LVDT was not exceeded when
using this lower compliance ex-fix.
Outcome measures for the data collected from the tests of each fixation method were: average
device compliance, standard deviation and coefficient of variation (COV) to assess the inter-animal
variability, and the average R2 value and its COV as a measure of the goodness of fit of a linear model for
the compliance of each individual ex-fix. Finally, a least squares linear approximation for all of the
compliance data collected from both the bilateral and the unilateral groups and the associated R2 value
was calculated to determine the single compliance coefficient that most closely fit all of the experimental
displacement-load responses in each group.

Accuracy of Knee Distraction.
For future experiments our primary independent variable will be distraction of the knee joint (i.e.,
separation of the joint space). Therefore, we characterized how accurately the device distracted the joint
using five cadaveric animals. The knee distraction experiments were conducted using bilateral fixation,
since this approach will be used in future studies.
Knee distraction was calculated using both the fixator compliance for each specimen and the least
squares compliance for all specimens, and compared to an independent measurement of knee distraction
as obtained by the kinematic tracking system. The load across the joint was then plotted against
distraction as measured by: the kinematic system (our “gold standard”), the LVDT, and for both the
animal-specific and the least squares compliance correction factors. We calculated the root mean square
(RMS) error between the kinematic system and the displacements recorded by the LVDT and the
displacements predicted using the animal-specific and the least squares compliance correction factors.
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Measurement of Knee Distraction.
Measurements for knee distraction were obtained using a three-dimensional (3D) kinematic
tracking system (ProReflex MCU, Qualisys Inc., Gothenburg, Sweden). This system recorded knee
distraction by monitoring the 3D spatial position of reflective markers that were glued to the femoral and
tibial tunnel exits of the reconstructed cadaveric knees (Figure 3.4). The tracking system was accurate to
53 µm RMS error (2.6%) with a COV of 3.2% for displacements of 2.00 mm using a digital caliper (Fowler
Inc., Newton, MA) as our reference standard. The manufacturer-provided specifications stated a caliper
resolution of 10 µm, an accuracy of 20 µm and a repeatability of 10 µm.
Three-dimensional position data of each marker were recorded for 6 distraction cycles at 10 Hz. The
3D spatial coordinates of each marker were post-processed using a fourth order Butterworth low pass
filter with a 0.01 Hz cut-off frequency. The filter was implemented using the signal processing toolbox
available in MATLAB (Mathworks, Natick, MA). Subsequently, the magnitude of the distance between
markers on the tibia and femur was calculated over the six distraction cycles. Accuracy data was calculated
from the data of the sixth loading cycle.

62

Figure 3.4: The kinematic tracking system measured the 3D spatial position of reflective markers glued
to the femur and tibia, subsequently, displacement across the joint space was calculated. These data
were used to develop a correction factor to account for the compliance of the ex-fix.
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Pilot Study
The purpose of the in-vivo pilot study was to determine if the animals could tolerate the surgical
procedure, continuous wearing of the ex-fix, and daily loading regimen under anesthesia. With approval
of our Institutional Animal Care and Use Committee, fifteen male Sprague Dawley rats underwent surgical
placement of the ex-fix, along with ACL reconstruction of the right knee using a flexor digitorum longus
tendon (FDL) autograft. On post-operative day four, the animals began a ten day long loading regime,
consisting of a daily fifty cycles of knee distraction to 2.5 mm within a load limit of 2400 grams. Distraction
was performed in the CDM at 0.17 Hz, under 2% isoflurane anesthesia, resulting in total anesthesia time
of approximately twenty minutes, allowing for set up and loading.
Since femoral or tibial fracture is a concern in this small animal model, we evaluated for fracture
using high resolution anterior-posterior and oblique radiographs (Faxitron Model# MX-20 DC4, Faxitron
X-ray Corporation, Wheeling, IL). Images of each rat were obtained prior to the first loading session to
identify any peri-operative fractures, and then every two days over the course of the loading regimen. We
also monitored the daily load-displacement curves as an indicator of slip in the mechanical components
of the device, loosening at the pin-bone interface, or catastrophic failure of any of the tissues.
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Results
Average system compliance for all specimens using bilateral fixation was 42.4 ± 8.8 µm/N (Figure
3.5). This yielded a COV of 20.7%. Average system compliance using unilateral fixation was 145.2 ± 44.9
µm/N (Figure 3.5) yielding a COV of 30.9%. The average R2 value for fitting a linear equation to the
compliance data for the bilateral and unilateral fixation were 0.989 ± 0.005 and 0.988 ± 0.007,
respectively. This yielded a COV of 0.5% and 0.7% for bilateral and unilateral fixation, respectively.

Figure 3.5: Displacement-load responses of ten unilateral (left) and eight bilateral (right) external fixators
obtained from our in vitro loading experiments. The least squares linear approximation (solid lines) for
unilateral and bilateral fixation yielded a best-fit compliance of 143.4 µm/N and 41.3 µm/N with R2 values
of 0.72 and 0.92, respectively. The 95% confidence bands and the 95% prediction bands of the linear
approximation are designated with long dashes (inner lines) and short dashes (outer lines), respectively.

The least squares compliance for all the specimens with bilateral fixation was 41.3 µm/N with an R2
value of 0.92. The least squares compliance for all the specimens with unilateral fixation was 143.4 µm/N
with an R2 value of 0.72.
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The total RMS error in knee distraction with bilateral fixation using the animal-specific compliance
correction factor, the best fit correction factor, and compared to the LVDT were 43 µm, 179 µm and 746
µm, respectively (Figure 3.6). Maximum knee distraction in the experiments using bilateral fixation
averaged 1.11 ± 0.32 mm; therefore RMS error of the animal-specific compliance correction factor, the
best fit correction factor, and compared to the LVDT represents 3.9%, 16.1% and 67.2% of the average
distraction of the knee, respectively.

Figure 3.6: Sample data (specimen 6) comparing the knee displacements obtained from motion analysis
(Knee) to: 1) displacements measured by the LVDT; 2) predictions of knee displacement obtained using
the specific compliance correction factor for an individual animal (Specific); and 3) predictions of knee
displacement obtained using a least squares fit to all the data.
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The in vivo pilot study revealed that all animals survived surgical implantation of the external fixation
device. The fifteen rats in the pilot study were immobilized until post-operative day four. Prior to the first
loading session, three fractures (two femoral, one tibial) were detected with faxitron imaging. Over the
test period, two of the remaining twelve animals experienced fracture of the femur. No tibial fractures
were detected. One fracture occurred during the first loading session, and the other occurred during the
second day of loading. Ten animals survived the duration of ten days of loading and were sacrificed on
post-operative day fourteen. No fractures were detected on post-sacrifice images.
Examination of each animal’s load-displacement responses indicate that no catastrophic failure of
soft tissue across the joint space occurred during the course of testing (Figure 3.7). Major slipping in the
mechanical components or loosening at the pin-bone interface was also not evidenced by large drops in
load over the course of loading.

Figure 3.7: Load displacement curves from 50 cycles of knee joint distraction in the CDM as recorded by
the custom program from a single representative animal on day nine of the pilot study. The curves show
no evidence of loosening of the mechanical components or failure of the soft tissue, which would be
indicated by sudden drops in load
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Discussion
Injuries to ligaments and tendons compromise the stability and function of joints, which can
ultimately lead to osteoarthritis. Ligament reconstruction procedures using tendon grafts to repair these
injuries often require secure tendon-to-bone healing, yet little is known about the effect of mechanical
load on healing of these repairs. To investigate this question we have designed and characterized a device
that applies cyclic distraction to a reconstructed ACL in an in-vivo animal model. Unlike previous devices
which only allow for load deprivation or static loading of tendons and ligaments, our system provides for
the modulation of magnitude, frequency and onset of loading [107–109]. Our long-term goal is to identify
the optimal rehabilitation protocol for patients who have undergone knee ligament reconstruction.
The CDM with bilateral fixation exhibited linear deformation characteristics under the loading
conditions that it will experience in future experiments. This characteristic enables use of a first order
correction factor to account for deformation of the device. Furthermore, the external fixator showed
some variability in compliance (COV=21%) across animals. We are not surprised in this variability,
however, since numerous intra-operative parameters must be controlled by the surgeon when placing
the ligament graft and installing the fixator on the animal. These include location, length and angle of the
intra-cortical pins used to secure the rat to the fixator [110].
We designed the ex-fix to maximize stiffness incorporating use of bilateral pin fixation to decrease
fixator compliance relative to unilateral fixation. The results of this study revealed that bilateral fixation
decreased compliance by factor 3.5, decreased variability in compliance by factor 1.5, and improved
linearity of our best fit correction term by factor 1.3.

Furthermore, the average compliance of our

bilateral fixator (42.4 μm/N) was about 1.4 times more than a similar external fixator (29.5 μm/N)
employing unilateral fixation and 1.1 mm diameter bone pins; however, the variability in the compliance
of our device was about 1.8 times less than this design (COV=37%) [111]. Although use of larger diameter
pins would further decrease compliance, this proved difficult in our small animal model because of
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increased risk of fracture. Previous studies employing 1.1 mm pins in a rat femur loading model reported
about a 30% complication rate [111].
The least squares linear approximation of fixator compliance decreased RMS error of predicted knee
displacements by a factor of 4.2 compared to the LVDT-based measurements (decrease in RMS error from
67.2% to 16.1% of total knee distraction). Although the least squares approximation provided less
accurate predictions of knee displacement compared to the animal specific compliance correction factor
(3.9% error), it is impractical to include a specific correction for each individual animal, since measuring
knee motions with a kinematic system in each animal is too time-consuming. Fortunately, using the least
squares linear approximation of fixator compliance still yields acceptable error levels because target knee
displacements in subsequent experiments (1 to 2 mm) will be 6 to 11 times greater than the error in knee
displacement using the least squares correction factor (179 μm). For example, the ratio of maximum
knee displacement as measured via motion analysis (1.1 mm) in our evaluation of the bilateral fixator to
the error levels in predicted knee displacement using the best fit compliance correction factor (179
microns) is 6.2.
Overall, both the characterization of system compliance and the study of knee displacement accuracy
provide us with important guidelines for designing studies based on our primary independent
experimental variable, knee displacement. Specifically, these data provide us with basic information to
choose discrete levels of knee distraction that are both statistically greater than zero, and different from
each other. For example, since use of our least squares correction factor yielded 16.1% error in achieving
target displacements, we must ensure that target displacements in future test groups differ by at least
this much.
The novelty of the device stems from its ability to apply controlled distraction to a healing ACL
reconstruction in a convenient and cost-effective rodent model. The device allows the investigator to vary
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the time of onset of loading (immediately after surgery versus delayed), as well as the duration, frequency
and magnitude of knee distraction. There are a wide variety of readily available biologic assays to examine
the cellular and molecular response to different loading regimens. Additionally, the investigator can
combine these mechanical effects with cytokines believed to modulate tendon to bone healing [112,113].
At the time of this writing, we have successfully performed ACL reconstructions and placed the
external fixator on almost 200 animals, with an overall fracture rate of approximately 15%, and minimal
other complications during loading in the CDM [9,114]. Our overall experience with this pilot study and
other subject groups shows that rodents tolerate the external fixator and daily loading under anesthesia
well, with no discernible adverse effects, and their cage activity is not unduly encumbered by the external
fixator. Further study may be required to evaluate the physiological effects of daily anesthesia on tendon
to bone healing, but is not the subject of this validation paper.
There are several limitations to our animal model and device. First, there is some slack length in the
graft despite fixation under tension at the time of surgery, and there is likely variability in slack length
between animals. Although determining the slack length of each individual rat would be ideal, it is
impractical since the load contribution of other structures across the joint space masks the point at which
the graft begins to take up load. Alternatively, we characterized the average slack length and its variability
at time zero in vitro by dissecting down to the bone-tendon-bone construct. For subsequent studies, we
can then use this to choose appropriate knee displacement levels that exceed this amount. This would
ensure that most of the grafts experience mechanical stimulus at post-operative day zero. Since slack
length may change beyond day zero due to both healing between graft and bone, and changes in graft
mechanical properties, we focused on ensuring that our device could deliver known amounts of knee
distraction. Our ultimate goal is to reproducibly distract the knee to a target displacement.
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We also do not know the contribution of other soft tissues to the load-displacement response
obtained from the daily loading regimens. To gain a better idea of the force through the graft tendon,
we released the anterior joint capsule and all other major ligaments. However, the skin, the
neurovascular structures, posterior capsule and several muscle groups (hamstrings, adductors, and
gastrocnemius) cannot be transected because their elimination would compromise the viability of the
limb. Variation in the load displacement response may be due to healing or adaptation of these
surrounding structures. The unknown and changing contribution of the other soft tissues to the load is
the reason we decided to use displacement control instead of load control. These limitations, however,
are not relevant to the primary purpose of our loading system, which is to determine the impact of
known levels of mechanical stimulus (i.e., knee distraction) on the biology of tendon-bone healing.
In conclusion, we have developed a new procedure and device for applying controlled mechanical
stimulus to a healing ACL graft over time in a small animal model. Our evaluation of the device compliance
and accuracy of knee distraction yielded important information that will guide us in defining groups with
statistically different levels of knee distraction. Our in vivo assessment revealed that the animals tolerated
the external fixator and daily anesthesia. Overall, this test system provides an important tool in achieving
our ultimate goal of studying the effect of the timing and magnitude of motion on tendon-to-bone healing,
and to identify and evaluate the mechanisms by which mechanical stimuli affects tendon-to-bone healing.
Acknowledgment
This work was supported by a grant from the National Institute of Health (R01 AR053689-01). The
authors gratefully acknowledge Luis Hernandez of the City College, CUNY for his help in prototype
manufacturing.

71

Chapter IV:
Effect of short-duration low-magnitude cyclic loading versus immobilization on tendon-bone
healing after ACL reconstruction in a rat model
Chapter four describes the initial use of the CDM device with external knee fixator in fulfillment
of aim two: the determination of the effect of cyclic tensile loading on tendon to bone healing.
Specifically we tested our first hypothesis that immediately following ACL_R, continual daily tensile
loading of graft tendon, for up to four weeks will impair tendon to bone healing, compared with
continuous strain shielding of the tendon graft [114].
This hypothesis predicts that compared with knee immobilization, daily graft loading via knee
distraction for periods of two and four weeks will result in: (1) more inflammatory and osteoclast cells at
the tendon-bone tunnel interface, along with increased angiogenesis; (2) less new bone formation; and
(3) reduced failure load and stiffness of the femur-graft-tibia complex.

Materials and Methods
Surgical Procedure
With Institutional Animal Care and Use Committee approval, fifty two male Sprague-Dawley rats
of weight 250-350 grams, received ACL_R of the lower right limb. In each, the flexor digitorum longus
tendon was harvested from the same limb for use as the tendon graft. Through a medial knee incision,
the patellar tendon, both collateral ligaments, original ACL and PCL were severed, to prevent these
structure from shielding the tendon graft from tensile load during protocol sessions.
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With a 1.2 mm diameter Keith needle, a tunnel was drilled through the medial diaphysis of the
tibia, aiming carefully to exit through the original ACL enthesis on the tibial plateau. With the needle left
protruding through the tibial tunnel, the knee was flexed until the needlepoint centered on the femoral
enthesis within the intercondylar notch, and a coaxial tunnel was drilled through the lateral condyle.
The Keith needle was left temporarily in place within both tunnels, while temporary ex-fix
mounting jigs were slipped over each end. These jigs held the femoral and tibial halves of the knee ex-fix
parallel with their respective tunnels, while each was secured with two 0.9 mm diameter Kirshner
threaded wires (1600-635T MicroAire Surgical Instruments, Charlottesville, Virginia), drilled into the
diaphysis of the femur and tibia, (see chapter 3). All joints were securely tightened and the jigs removed,
leaving the knee locked in approximately 60 degrees flexion.
The Keith needle was then used to shuttle the tendon graft through both tunnels. The graft was
placed under light tension and sewn to the periosteum at the diaphyseal tunnel exits using 3-0 Ethibond
non-degradable suture, by the same surgeon in all 52 animals. Average graft length was 15 mm from
tunnel exit to tunnel exit. All wounds were then sutured closed and the rats given pain medications
upon revival.

Figure 4.1: Placement of Ex-fix during ACL_R surgery. The Keith needle temporarily remains in place
after drilling both bone tunnels, while used with jigs to guide ex-fix placement in relation to the tunnels.
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Study Design
After surgery all rats were randomly assigned into treatment or control groups. The treatment group
received daily sessions of cyclic knee joint distraction beginning on postoperative day one for a period of
either 14 or 28 days. Control group subjects received postoperative knee immobilization via contiuous
wearing of the the ex-fix, again for periods of either 14 or 28 days. Subjects were sacrificed at the end of
their assigned period.

52 SD Rats
Receive
ACL_R

Day 0
Figure 4.2: Study Design

26 Rats
Continuous-Immobilization
26 Rats
Immediate-Loading
Postoperative
Day 1

Sacrifice
Day 14

Sacrifice
Day 28

Determination Tendon Graft Strain Effected Through Knee Joint Distraction
Due to concerns over potential slack length left in the tendon graft after surgery reducing the
effective strain applied during cycles of knee joint distraction, a pilot study was first completed using the
same surgeon performing the identical ACL_R procedure described above on nine cadaver rats.
Using the optical tracking system described in chapter three [115], we measured the actual joint
space distraction by tracking reflective markers placed on the femur and tibia. Although the cyclic
displacement mechanism (CDM) moved the tibial portion of the ex-fix a commanded 1.5 mm distally,
the mean joint distraction achieved in the nine cadavers (optically measured) was 0.88 ± 0.33 mm, due
primarily to deflection of the 0.9 mm k-wires connecting the femur and tibia to the ex-fix.
Slack length in the graft was defined as the optically measured joint distraction distance reached
when 30 grams of tension was measured through the isolated femur-graft-tibia complex. Therefore any
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surrounding tissue that could contribute force across the joint space was dissected away in each of the
nine specimens until only the femur-graft-tibia complex remained. The mean slack length at 30 grams of
force across the joint space in the nine cadaver specimens was 0.55 ± 0.23 mm.
The mean total joint space distraction (effective graft elongation) for this study was defined as
mean joint space distraction (0.88 mm) minus mean slack length (0.55 mm), and equal to 0.33 mm.
Normalizing this by the average free initial graft length of 15 mm equates with an effective tendon graft
strain of 2.2 %. This correlates with human studies estimating from 2 to 5 % elongation of both the
native ACL and reconstruction grafts during light rehabilitation exercises.

Daily Loading Protocol
Beginning on postoperative day 1, rats in the treatment group received fifty cycles of cyclic knee
distraction daily until the day before sacrifice at the end of their assigned period on day 14 or 28. After
induction of 2 % isoflurane anesthesia, the rat was placed in the cyclic distraction mechanism (CDM)
with the femoral and tibial components of the ex-fix connected to the load cell and actuator
respectively. To establish a consistent starting position across subjects, the actuator first compressed
the knee joint until -1.96 N (-200 grams) of force was read. The actuator then commenced fifty cycles of
FDL tendon graft strain, each consisting of knee joint distraction to the target distance and return to the
starting position, both at 0.24 mm/sec.

Histological Analysis
Twelve limb specimens were randomly assigned for histology, three for each treatment group
and their time period subgroups. Each limb was divided at the graft mid-substance into separate tibial
and femoral specimens, which were then fixed and decalcified. After embedding in paraffin the tibia was

75

cut into 5 µm thick coronal sections and the femur into 5 µm thick sagittal sections. These were then
stained with hematoxylin and eosin, safranin-O, and picosirius red.
For immune-histochemical analysis, serial sections were treated with 3% H2O2 to quench
endogenous peroxidase activity, and nonspecific antibody binding was blocked with 5% goat serum.
Each primary antibody was applied to separate serial sections for sixty minutes at 37_C. Bound
antibodies were visualized with use of a goat avidin-biotin peroxidase system with 3,3’diaminobenzidine (DAB; DAKO, Carpinteria, California) as a substrate.
Hematopoietic lineage cells were bound by the following antibodies: rabbit anti-rat neutrophil
PMN (Accurate Chemicals, Westbury, NY), mouse anti-rat ED1-macrophage (ED1 antigen is a lysosomal
glycoprotein expressed only by a subpopulation of macrophages and monocytes) and mouse anti-rat
ED2-macrophage (ED2 antigen is a membrane glycoprotein found only on mature tissue macrophages)
(Serotec, Raleigh, North Carolina). Osteoclast activity was evaluated by staining for tartrate-resistant
acid phosphatase (TRAP; Zymed, San Francisco, California). Type-I procollagen stain (Santa Cruz
Biotechnology, Santa Cruz, California) was used as an indicator of collagen synthesis by osteoblasts.
Proliferating blood vessels were localized with rabbit antihuman factor VIII (DAKO). Negative controls
were processed in an identical manner except for incubation with bovine serum albumin rather than the
primary antibody.

Analysis of Histological Data
Digital images of the stained tissue sections were made were made through light microscopy
(Eclipse E800; Nikon, Melville, New York), using a SPOT RT camera (Diagnostic Instruments, Sterling
Heights, Michigan). An observer counted the number of positively stained cells in thirty randomly
selected 40-power, 100 by 100-µm fields from the tibial bone tunnel, the femoral tunnel was excluded
because of variability due to its thinner diameter.
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Micro-Computed Tomography Analysis
Sixteen limb specimens underwent scanning by micro-CT (MS-8 Small Specimen Scanner;
Enhanced Vision Systems, London, Ontario, Canada), four from each group at the two and four week
time points, with a time zero scan of three specimens for a baseline comparison. Both tibial and femoral
tunnels were scanned at 80 V and 80 mA and reconstructed at 22.5-µmm resolution.
Bone formation and remodeling were evaluated with six quantitative measures: bone volume
(mm3), tissue mineral content (mg), tissue mineral density (mg/mL), trabecular thickness (µm),
trabecular number, and trabecular spacing (µm).
Total mineral content, mineral distribution and bone volume fraction (bone volume divided by
total volume), were calculated for a cylinder of 2.2 mm diameter superimposed over the entire length of
the graft tunnel. An SB3 standard of 1100 g of hydroxyapatite/cm3 was used to calibrate tissue mineral
density. The mineral distribution was determined from the computed tomography value for each voxel
of the micro-CT scan. The bone volume is the total of bone voxels within this cylinder.

Biomechanical Testing
Twenty-four ACL_R limb specimens, six for each time point and group, were stored at – 80° C.
Several hours before testing they were thawed and all soft tissue dissected, leaving only the femurgraft-tibia complex. Both tibial and femoral ends were potted in cement to provide a secure gripping
surface (Bondo; 3M Corp., Atlanta, Georgia). The potted ends of each specimen were securely mounted
in the grips of a custom tensile test machine, with the graft parallel to grip translation.
Five cycles of preconditioning distraction preceded from 0 to 0.2 N load. The load to failure test
followed with one potted end of femur-graft tibia complex displaced at 10 mm per minute until the
recorded load peaked, and the specimen visibly failed. The stiffness (N/mm) and ultimate load (N) were
calculated from the linear portion and peak, respectively of the recorded load-displacement relation,
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using Microsoft Office Excel 2002 (Microsoft, Redmond, Washington). The site and of mode failure
(tunnel pull-out or mid-substance graft rupture) were also recorded.

Statistical Analysis
One way analysis of variance with repeated measures was used to assess variations in the mean
load at maximum knee distraction for each animal over the treatment period. A custom program was
written in Matlab 6.1 (The MathWorks, Natick, Massachusetts) to read the daily CDM data and extract
the load at maximum displacement from cycles 21 to 30 to calculate these averages. A student t-test
compared the mean load averages between the two and four week daily knee distraction groups at
various time points.
Additionally, on the day of sacrifice at either two or four weeks, the immobilization group
underwent one sole knee distraction period of 50 cycles, solely to allow for comparison of maximum
load, between both treatment groups. Systat Software (Chicago, Illinois) and SAS 9.1 for Windows (SAS
Institute, Cary North Carolina) were used for the statistical tests, with a significance criteria of p < 0.05.

Results
Inflammatory Cells
Significantly more ED1+macrophages (Table 1) were counted in the two week-knee distraction
group (3.0 ± 1.5 per field) than in the two week-immobilization group (2.4 ± 1.5 per field) (p=0.01).
However there were no significant differences in ED1+ macrophages between the four week-distraction
and four week-immobilization groups. Within the distraction treated rats there were significantly less
ED1+ macrophages counted (1.9 ± 1.4 per field) in the four week group than in the two week group (p =
0.03). Counts of ED2+ macrophages showed no significant differences between treatment groups at
either time point, nor within either group between time points. Few neutrophils were counted [114].
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TABLE 4.1: Inflammatory Cell Histology Data [114]
Cells per High-Power Field
Marker and Time Point
ED1+ cells
2 weeks
Mean
Median
Standard deviation
4 weeks
Mean
Median
Standard deviation
ED2+ cells
2 weeks
Mean
Median
Standard deviation
4 weeks
Mean
Median
Standard deviation
Polymorpohonuclear cells
2 weeks
Mean
Median
Standard deviation
4 weeks
Mean
Median
Standard deviation

Continuous - Immobilization Immediate - distraction

2.4a
2.0
1.5

3.0a,b
3.0
1.5

2.6
3.0
1.5

1.9b
2.0
1.4

1.6
1.0
1.8

1.2
1.0
1.3

0.8
0.0
1.3

1.4
1.0
1.3

0.6
0.0
1.0

0.3
0.0
0.6

0.3
0.0
0.8

0.2
0.0
0.7

*

The letters a and b identify the two data points being compared in each case, with a indicating a p value
of 0.01, and b indicating a p value of 0.03.
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Angiogenesis
Counts of Factor-VIII stained cells showed no significant difference (p = 0.08) between the two
week-knee distraction group and the two week-immobilization group. Although within the distraction
groups the two week group exhibited 1.6 cells per field while the four week group only 0.7 per field, the
difference was not significant (p = 0.08).

TABLE 4.2: Angiogenesis Histology Data [114]
Cells per High-Power Field
Factor VIII

Continuous - Immobilization

Immediate - distraction

2 weeks
Mean
Median
Standard deviation

0.8a
0.0
1.0

1.6a,b
2.0
1.1

4 weeks
Mean
Median
Standard deviation

1.1
0.0
1.4

0.7b
0.0
0.9

*

The letters a and b identify the two data points being compared in each case, with both a and b
indicating a p value of 0.08.
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Osteoclasts and Osteoblasts
The was no significant difference in tartrate-resistant acid phosphatase stained cells between
immobilized and knee distraction groups at either time point. Within the immobilized rats, the
difference between the 2 week group (1.4 cells per field) and the four week group (0.7 cells per field)
was not significant (p = 0.07). No significant differences in procollagen staining between groups or
between time points were found.

TABLE 4.3: Bone Homeostasis Histology Data [114]
Cells per High-Power Field
Marker and Time Point Continuous - Immobilization Immediate - distraction
TRAP staining
2 weeks
Mean
Medi an
Standard deviation
4 weeks
Mean
Median
Standard deviation
Procollagen staining
2 weeks
Mean
Median
Standard deviation
4 weeks
Mean
Median
Standard deviation

1.4a
1.0
1.2

1.0
1.0
1.0

0.7a
0.0
1.0

1.2
1.0
0.9

1.7
2.0
1.2

3.2
3.0
1.7

2.6
3.0
1.7

2.0
2.0
1.6

*

The letter a, identifies the two data points being compared, and indicates a p value of 0.07. TRAP =
tartrate-resistant acid phosphatase.
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Micro-CT
The mean and standard deviation of data from the micro CT scans are shown in Table IV. Within the
knee distraction group rats, the number of trabeculae after 4 weeks was significantly lower (p = 0.02)
than at time zero. No other differences between treatment or time groups proved significant.

TABLE 4.4: Micro-Computed Tomography Data [114]
2 Weeks

4 Weeks

Continuous Immobilization
(N = 4)

Immediate distraction
(N = 4)

Continuous Immobilization
(N = 4)

Immediate distraction
(N = 4)

Bone volume
0.82 ± 0.04
(mm3)

0.85 ± 0.19

0.89 ± 0.30a

0.88 ± 0.28b

0.61 ± 0.09a,b

Total mineral
0.45 ± 0.03
content (mg)

0.48 ± 0.12

0.49 ± 0.15

0.49 ± 0.17

0.37 ± 0.08

Time Zero
(N = 3)

Total mineral
density
(mg/mL)

543 ± 25

542 ± 32

536 ± 40

534 ± 40

575 ± 39

Trabecular
thickness
(μm)

61.6 ± 2.6

69.8 ± 13.1

67.5 ± 13.2

66 ± 11.3

58.2 ± 2.66

Trabecular
number

3.71 ± 0.28c

2.94 ± 0.33

2.94 ± 0.33

2.75 ± 1.02

2.61 ± 0.33c

Trabecular
spacing (μm)

246 ± 30d

280 ± 45

297 ± 68

368 ± 188

375 ± 51d

The values are given as the mean and standard deviation. The letters a, b, c, and d identify the two data
points being compared in each case; a indicates a p value of 0.07, b indicates a p value of 0.08, c
indicates a p value of 0.02, and d indicates a p value of 0.09.
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Biomechanical Testing
Data from daily knee distraction
Among the rats experiencing daily knee distraction, the mean load at maximum knee distraction
increased over time: from 5.7 ± 2.3 N on postoperative day one to 9.8 ± 2.4 N on day fourteen (p = 0.04),
and from 4.1 ± 0.9 N on postoperative day one to 9.4 ± 4.0 N on day twenty-eight (p = 0.03). For all
groups loads measured on day 10 were significantly greater than day five (p= 0.01), loads on day 12
were significantly greater than those on day seven.
For the one time knee distraction of the immobilized groups immediately before sacrifice, the
mean load measured on day fourteen was 10.7 ± 2.9 N and on day 28 was 10.9 ± 4.6 N.

Figure 4.3 Graph of the mean load achieved each day of the rats in the immediate-loading group [114].
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Stiffness and Load to failure
The mean stiffness data for each group and time point are shown in figure 4.3. Within the
immobilized rats the mean stiffness of the four week group 6.4 ± 2.9 N/mm was significantly greater
than the two week group 3.8 ± 1.4 N/mm. There was no significant difference between the knee
distraction and immobilized groups at either time point.

Figure 4.4 Mean stiffness from the load to failure test of the femur-graft-tibia complex [114].
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The mean Load to failure for each group and time point is shown in figure 4.4. At two weeks the
mean load to failure was almost identical at 4.4 N in both the knee distraction and the immobilization
groups. By four weeks the mean failure load increased significantly, almost doubling in both groups, 8.2
± 3.6 N (p = 0.02) for the knee distraction group and 8.7 ± 2.3 N (p = 0.009) for the immobilized. No
significant differences in load to failure were found between knee distraction and immobilization groups
at either time point. The mode of failure was though pulling out of the bone tunnel in twenty-three out
of twenty-four specimens, with one of the four week immobilization group failing through the midsubstance of the graft.

Figure 4.5: Mean load to failure of the femur-graft-tibia complex [114].
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Discussion
This study is the first to apply controlled tensile load onto a healing tendon graft in-vivo, in a rat
model of ACL_R, using a novel device. Previous studies of the effects of mechanical load on tendon to
bone healing were limited to unquantifiable methods such as ad-libitum cage motion and treadmill
running. We tested the hypothesis that immediate tensile graft strain, applied daily for periods of up to
two and four weeks, would impair tendon graft to bone healing compared with continuous strain
shielding of the graft.
Results showed that 2 % tensile strain applied to the tendon graft daily for two weeks post
ACL_R surgery resulted in a significantly greater accumulation of macrophages within the tendon- bone
interface at the two week time point. This partly supports our first prediction of a greater accumulation
of inflammatory cells, although there was no significant increase in angiogenesis.
Regarding our second prediction of less new bone formation, histology showed no significant
differences in cells stained for either TRAP or procollagen between groups at either time point, implying
no differences in osteoclasts or osteoblast activity. However, the micro CT analysis counted fewer
trabeculae at the 4 week-distraction group, when compared to a baseline analysis of three specimens at
time zero, providing support for the second prediction.
Our third prediction of reduced stiffness and failure load was not supported, as both groups
showed no significant differences in either measure, at either time point. Remarkably the mean load to
failure for both groups was n nearly identical at 4.4 N in both groups at two weeks, and almost doubling
to 8.7 N (immobilization) and 8.2 N (distraction) at the four week time point.
As with all studies there were limitations. The initial tension on the graft during surgical
placement could not be reliably quantified, instead we relied on a single surgeon for repeatable graft
placement. The duration and magnitude of mechanical stimulation required to affect healing may be
greater than daily 50 cycles we applied or our average 2 % graft strain. However addition of greater
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strains, more cycles, and additional daily sessions would increase the amount of time under anesthesia
for each subject. Attempts at increasing strain through increased joint distraction distance met with
diminished returns due to greater bending of the k-wires through the femur and tibia, compounded with
an increased the risk of fracture.
Although only modest differences were shown between knee distraction and knee
immobilization groups, this study will provide a baseline for future studies varying additional parameters
such as strain magnitude and post-operative delay periods prior to the onset of the daily strain protocol.
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Chapter 5
Effect of early and delayed mechanical loading on tendon-to-bone healing after anterior
cruciate ligament reconstruction

Introduction
While Chapter Four compared the effect of the daily tendon graft loading versus continuous
load shielding, Chapter Five fulfills aim three by adding an additional variable, delay of treatment onset,
by imposing a period of immobilization to shield the tendon graft from mechanical load, prior to
beginning the daily loading treatment on postoperative day four (group three) or day ten (group four).
This study will test hypothesis H1, which states that an immediate postoperative period of load
shielding lasting up to four or ten days, followed by a daily regime of tendon graft loading, ending on
either postoperative day 14 or 28, will improve tendon graft to bone tunnel healing, compared to both
continuous load shielding and immediate daily loading beginning postoperative day one.
Hypothesis H1 predicts that in those animals where tensile loading was delayed, there will be: (1)
Fewer inflammatory and osteoclast cells at the tendon-bone tunnel interface, along with reduced
angiogenesis; (2) More new bone formation; and (3) Increased failure load and mechanical properties of
the femur-graft-tibia complex.
Materials and Methods
Surgical Procedure
Animal Care and Use Committee approval was received for the use of 156 male Sprague-Dawley
rats of weight 250-350 grams, approximately 11 weeks old, to receive ACL_R of the lower right limb. The
identical surgical procedure described in Chapter Four, including placement of the ex-fix, was performed
for all 156 subjects. Because each rat recovered from the surgery wearing the ex-fix, the knee joint of
the right lower limb was immobilized at time zero.
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Study Design
All rats were randomly assigned into one of the following treatment regimes (Figure 5.1):
(1) Continuous Immobization.
(2) Daily sessions of the loading treatment to begin on postoperative day one.
(3) Immobilization through postoperative day three - daily loading treatment sessions begin on day four.
(4) Immobilization through postoperative day nine - daily loading treatment sessions begin on day ten.
All subjects were sacrificed at the end of their study group length of 14 or 28 days.

Figure 5.1: Study design
Tendon Graft Strain During Knee Joint Distraction
As described in Chapter Four, a mean distraction distance of 0.88 ± 0.33 mm was calculated
from the optically measured knee joint distraction distances achieved in nine rat cadaver ACL_R
specimens. From this distance the mean graft slack length of 0.55 ± 0.23 mm, at 30 grams of tension was
subtracted to give an average graft elongation of 0.33 mm. Normalizing this by the average graft length
of 15 mm gives an effective graft strain of 2.2 %.
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Daily Treatment Protocols
As in Chapter Four, those rats assigned “continuous immobization” (group 1) continuously wore
a locked ex-fix for either 14 or 28 days. Those assigned “immediate loading” (group 2) received the
loading treatment daily from postoperative day one until either day 14 or day 28, corresponding with
the end of their study group. (Note, this study applied data from Chapter Four to groups 1 and 2,
expanding these groups to 36 subjects each). Rats assigned to “delayed onset” groups continuously
wore the locked ex-fix after surgery until the beginning of daily loading treatments, on either
postoperative day four (group 3) or day 10 (group 4); see Figure 5.1.
Each daily loading treatment session (groups 2, 3 and 4) began with sedation of the subject rat
via inhalation of a 2 % isoflurane - oxygen mixture. The rat was then placed in the loading mechanism
(the cyclic distraction mechanism, CDM of Chapter 3) and the ex-fix locking bar removed. The CDM
actuator initially compressed the knee joint until negative 1.96 N (-200 grams) of force was applied,
establishing a baseline starting point for distraction control. Fifty cycles of tendon graft loading
(elongation) commenced via the CDM alternately distracting and retracting the knee joint at 0.24
mm/sec. The distraction was applied in a reciprocating translation co-linear with the axis of both bone
tunnels. After the fiftieth cycle, the locking bar was replaced in the ex-fix before removing the rat from
the CDM for revival, immobilizing the knee until the following days treatment [115].

Histological Analysis
Histological and immunohistochemical analyses were performed identically as detailed in
Chapter Four, with the details omitted here for brevity (see Chapter 4). However the following changes
to the list of stains and antibodies were made:
Use of picrosirius red staining and type-I procollagen staining were not continued. Use of the
antibody for neutrophils was not continued. The antibody used to detect proliferating blood vessels,
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rabbit anti-human factor VII was replaced with a mono-clonal antibody to α-smooth muscle actin (αSMA), a marker of vascular pericytes, (Sigma, St. Louis, Missouri). Histological staining continued using
hematoxylin and eosin, and safranin-O.
Immunohistochemical analysis used the following antibodies: mouse anti-rat ED1-macrophage,
mouse anti-rat ED2-macrophage, and a monoclonal antibody to α-SMA. Chemical staining was used to
detect tartrate resistant acid phosphatase (TRAP) secreted by osteoclasts.

Analysis of Histological Data
Digital images of the stained tissue sections were made through light microscopy (Eclipse E800;
Nikon, Melville, New York), using a SPOT RT camera (Diagnostic Instruments, Sterling Heights, Michigan).
An observer counted the number of positively stained cells in thirty randomly selected 40 power, 100 by
100-µm fields from the tibial bone tunnel, the femoral tunnel was excluded because of variability due to
its thinner diameter.

Micro-Computed Tomography Analysis
Micro-CT scanning was performed with using the same procedure detailed in Chapter Four.
However scanning was limited to tibial specimens because of their reduced variability in bone tunnel
length. Two specimens were added at time zero scan to increase the baseline reference group to five.
Bone formation and remodeling were evaluated with six quantitative measures: new bone
volume (mm3), tissue mineral content (mg), tissue mineral density (mg/mL), trabecular thickness (µm),
trabecular number, and trabecular spacing (µm).
Two-way analysis of variance was used to detect differences in the histological and micro CT
data between the four treatment groups. Repeated-measures analysis of variance was also used to
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detect changes with location along the same bone tunnel (articular aperture, mid-length and diaphyseal
aperture), from the histology slides of a single specimen (Figure 5.5).

Biomechanical Testing
After sacrifice at the two and four week time points, the limb specimens were harvested and
stored at – 80° C. Several hours before testing they were thawed and all soft tissue dissected, leaving
only the femur-graft-tibia complex. Both tibial and femoral ends were potted in cement to provide a
secure gripping surface (Bondo; 3M Corp., Atlanta, Georgia).
The potted ends of each specimen were securely mounted in the grips of a custom tensile test
machine, with the graft axis parallel to the grip translation. Five cycles of preconditioning distraction
were given from 0 to 0.2 N load. The load-to-failure test followed with one potted end of femur-graft
tibia complex displaced at 10 mm per minute until the load peaked, and the specimen visibly failed. The
load-elongation data and failure site (mid-substance tendon graft rupture, graft pull-out from either
femoral or tibial bone tunnels, or failure through the phsysis) were digitally recorded for each specimen.
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Results
Inflammatory Cells
Significantly less ED1+ macrophages were counted in the two delayed loading groups than in the
immobilized and immediate loading groups, at two and four weeks (p < 0.01, Table 5.1). Delaying knee
loading appeared to reduce average ED1+ macrophages averages by half (Figure 5.2).
An opposite effect was found for ED2+ macrophages, significantly more (p < 0.02) were counted
in both delayed loading groups than in the immobilized and immediate loading groups, at two and four
weeks. No significant differences were found between the continuous immobilization group and the
immediate loading group in the counts of either ED1+ or ED2+ macrophages [9].
Table 5.1: Quantitative Analysis of Cells at the Tendon-Bone Tunnel Interface
Cells per High Power Field
Continuous
Immobilization

Immediate
Distraction

4-Day Delayed
Distraction

10-Day Delayed
Distraction

ED1+ macrophages
2 weeks
4 weeks

2.42 ± 0.12 a
2.53 ± 0.82 c

2.96 ± 0.05 b
2.02 ± 0.91 d

1.49 ± 0.17 a,b
0.97 ± 0.21 c,d

0.63 ± 0.2 a,b
0.54 ± 0.13 c,d

ED2+ macrophages
2 weeks
4 weeks

1.71 ± 1.5 e
0.83 ± 0.6 g

1.14 ± 0.47 f
1.36 ± 0.16 h

2.62 ± 0.54 e,f
3.37 ± 0.29 g,h

2.97 ± 0.7 e,f
3.35 ± 0.51 g,h

Osteoclasts (TRAP)
2 weeks
4 weeks

1.44 ± 0.2 i
0.69 ± 0.08 k

1.02 ± 0.08 j
1.22 ± 0.17 l

0.58 ± 0.37 i,j
0.29 ± 0.14 k,l

0.35 ± 0.15 i,j
0.33 ± 0.15 k,l

Neovascularity (SMA)
2 weeks
4 weeks

0.78 ± 0.39 m
1.03 ± 0.62 o

1.54 ± 0.22 n
0.83 ± 0.46 p

0.3 ± 0.17 m,n
0.31 ± 0.16 o,p

0.27 ± 0.15 m,n
0.22 ± 0.1 o,p

Group

Data are reported as the mean and standard deviation. Values that share a letter were
significantly different from one another, with a, b, c, d, i, j, k, and l indicating p < 0.01;
e, f, g, and h indicating p < 0.02; and m, n, o, and p indicating p < 0.003.
(Bedi, A. et al. J Bone Joint Surg Am 2010;92:2387-2401)
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Figure 5.2: Immuno-histochemical staining for ED1+ and ED2+ macrophages. (Upper chart) Significantly
less ED1+ macrophages were counted in the two and four week delayed-knee loading groups than in the
immobilized and immediate loading groups, at two and four weeks (p < 0.01). (Lower chart) Significantly
more (p < 0.02) were counted in both delayed loading groups than in the immobilized and immediate
loading groups, at two and four weeks. (Cells/HPF = Average number of cells counted per high-power
field) [9].
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Angiogenesis
In the two and four week delayed loading groups, staining for smooth muscle actin revealed less
neovascularity, than in the continuous immobilization or immediate loading groups (Figure 5.3).

Figure 5.3:
Counting of cells staining for smooth-muscle-actin (SMA) showed reduced interface tissue vascularity in
both the two and four week delayed-knee loading groups compared with that in the immediate-loading
or continuous immobilization group at two and four weeks postoperatively (p < 0.003). (Cells/HPF =
Average number of cells counted per high-power field) [9].
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Osteoclasts
Significantly less cells staining positive for tartrate resistant acid phosphatase were counted in the two
and four week delayed-loading groups than in the continuous-immobilization or immediate-loading
groups (p > 0.01, see Table 5.1 and Figure 5.4). No significant differences were found between the
continuous immobilization group and the immediate loading group in the counts of cells staining
positive for TRAP [9].

Figure 5.4 Significantly less osteoclasts were observed at the tendon-bone interface in the two and four
week delayed-knee loading groups compared with the number in the immediate-loading or continuous
immobilization group at two and four weeks postoperatively (p < 0.01). (Cells/HPF = Average number of
cells counted per high-power field) [9].
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Micro-Computed Tomography
The new-bone volume, tissue mineral content, and tissue mineral density observed in the tibial
tunnels of the delayed-loading groups were significantly greater than those in the immediate-loading
and continuous-immobilization groups at both two and four weeks postoperatively (new-bone volume,
1.47 ± 0.11 mm3 [postoperative-day-10 group] versus 0.89 ± 0.30mm3 and 0.85 ± 0.19mm3 [immediateloading and immobilization groups, respectively] at two weeks; p < 0.003; Table 5.2 and Figure 5.6.
No significant differences in new bone volume, tissue mineral content, or tissue mineral density
were observed between the continuous-immobilization and immediate-loading groups at any time
point. Regional tunnel analysis revealed that the new-bone volume, tissue mineral content, and tissue
mineral density at the intra-articular aperture (p < 0.01) and mid part of the tunnel (p < 0.01) were
significantly greater in the delayed-loading groups than they were in the continuous-immobilization or
immediate-loading group, but there were no differences between groups at the extra-articular aperture
[9].
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Table 5.2: Micro-Computed Tomography Analysis of the Tibial Tunnels

Time Zero

Continuous
Immobilization

Immediate
Distraction

New bone vol. (mm3)

0.82 ± 0.04

0.85 ± 0.19

0.89 ± 0.30

1.60 ± 0.54†

1.47 ± 0.11†

Tissue mineral
content (mg)

0.45 ± 0.03

0.48 ± 0.12

0.49 ± 0.15

1.05 ± 0.38‡

0.97 ± 0.09‡

543 ± 25

542 ± 32

536 ± 40

639 ± 16‡

643 ± 21‡

New bone vol. (mm3)

0.82 ± 0.04

0.88 ± 0.28

0.61 ± 0.09

1.32 ± 0.19§

1.44 ± 0.45‡

Tissue mineral
content (mg)

0.45 ± 0.03

0.49 ± 0.17

0.37 ± 0.08

0.92 ± 0.13‡

1.03 ± 0.34‡

543 ± 25

534 ± 40

575 ± 39

684 ± 27†

706 ± 18†

Group

4-Day Delayed 10-Day Delayed
Distraction
Distraction

2 weeks

Tissue mineral
density (mg/mL)
4 weeks

Tissue mineral
density (mg/mL)

P < 0.003 compared with the immobilization and immediate-loading groups
‡P < 0.001 compared with the immobilization and immediate-loading groups
§P < 0.01 compared with the immobilization and immediate-loading groups.
(Bedi, A. et al. J Bone Joint Surg Am 2010;92:2387-2401)

Figure 5.5: Sagittal micro-computed tomography images of the tibial tunnel. New-bone formation,
tissue mineral content, and tissue mineral density were quantified for the entire tibial tunnel as well as
for the intra-articular aperture A, mid-part of the tunnel B, and extra-articular aperture C [9].
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Figure 5.6: Significantly greater new-bone volume (NBV) was observed in the tibial tunnels of both
delayed loading groups compared with that in the immediate-loading or immobilization group at two
and four weeks postoperatively (p < 0.003) [9].
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In a preliminary analysis of the load to failure data by Bedi et al, the stiffness (N/mm) and
ultimate load (N) were calculated from the linear portion and peak respectively, of the recorded loaddisplacement relation using Microsoft Office Excel 2002 (Microsoft, Redmond, Washington), however
they did not separate those results by mode and site of failure. For the purposes of this dissertation a
more in-depth analysis of the load-to-failure data was conducted as detailed in the following section.

Statistical Analysis of Load-to-Failure Mechanical Tests
To model the force-elongation response of the rat ACL-R, the load-to-failure data of the femurgraft-tibia specimens (N = 63) were fit to two response models by a least squares algorithm, using
Matlab Release 15 software (The MathWorks Inc, Natick, MA). An exponential growth curve (Fung
model); F = a(ebx -1) was first used as a model because it shows the slow initial nonlinear response of the
tendon graft - the “toe region” typical of soft biological tissues, followed by a more linear
response[116]. As it became clear that many data sets (n ≈ 26) exhibited a purely linear response to
elongation, a second linear fit model; F = mx, was used. Figure 5.7A shows an example of a successful
exponential fit of one data set with the exponential growth model, while Figure 5.7B shows a successful
fit for the linear model. A less effective fit using the exponential model is shown in Figure 5.7C, where
the linear model was clearly more appropriate for a linear model.

For each data set, the yield load and yield elongation were visually chosen from the datum point
at which force stopped increasing linearly with elongation. Both exponential and linear models were fit
from the zero load - zero elongation point up to the individual yield point. The data from the exponential
curve and linear models for each load-to-failure test are listed by row in Table 5.4 and include the
following:
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Coefficients a and b predicting the exponential curve fit F = a(ebx -1) with their respective p-values for
each test - together with the slope for the linear fit (columns six through ten).
The yield load (N), yield elongation (µm), maximum load (N) and maximum elongation (µm) (columns 11
through 14).
The site of failure for each femur-graft-tibia specimen (column 15):
femoral tunnel pull-out (Fem-Tnl) n=16; tibial tunnel pull-out (Tib-Tnl) n=26; pull-out via both
femoral and tibial tunnels (Both Tnls) n=12; mid substance tendon graft failure (Mid-Subs) n=4;
failure through the tibial physis (Tib-Physis) n =2; or as a combination of tunnel pull out and midsubstance failure (MdSB/T-Tn or MdSB/F-Tn; n =3).
Columns eight and nine of Table 5.4 show the respective p-values for coefficients a and b of the
exponential curve model F = a(ebx -1), calculated to determine the level of probability that this model,
fits these data (SigmaPlot 10, Systat Software Inc, San Jose CA). Those specimens with p-values greater
than 0.05 (n = 26) are better represented by the linear fit slope shown in column ten.

We initially explored significant relationships between the data and experimental treatments
using two-way ANOVA using Minitab17 software, (Minitab Inc. State College, PA.). However because
ANOVA will only determine significant differences between treatment means, we chose to implement
multiple linear regression to better reveal any relationships between delay periods, treatment
durations, and study group lengths and the outcome variables (mechanical parameters) .
The response or dependent variables assessed by regression included the coefficients of
exponential curve model; a and b, the slope of the linear fit, the yield load, yield elongation, maximum
load and maximum elongation, as listed in columns 6, 7 and 10 – 14 of Table 5.4.
The first independent regression variable, “Delay” in column 2 of Table 5.4, reflects four levels of
postoperative delay in days, prior to the onset of the daily loading treatment; with “four” indicating
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daily loading commencing on postoperative day four, “ten” indicating daily loading commencing on
postoperative day ten, “one” indicating loading commencing on day one (20 – 24 hours of true delay),
and “zero” indicating the continuously immobilized control group. Factor two (Group days) included the
treatment group lengths of either 14 or 28 days.
We included a third independent variable “Load (days)” in column 3 of Table 5.4, to account for
differences in the total number of daily loading treatments received between groups (equal to onset
Delay (days0 subtracted from Group (days)). However the regression model (in Minitab 17) failed to
attribute any significant effect to Load (days) due to its dependence on and nesting within the levels of
the Delay (days) variable. For example only the four-day delay group had a treatment length of either 10
or 24 days (2 weeks: 14 – 4 days delay, or 4 weeks: 28 – 4 days delay), and only the ten day delay group
had a treatment length of either 4 or 18 days (2 weeks: 14 – 10 days, or 4 weeks: 28 – 10 days).
Determining the significance of this factor would require a fully orthogonal study design with groups for
all levels of each treatment factor, filling the empty spaces of the matrix shown in Table 5.3.
Delay (days)
Ten Day
2 wk.
4 wk.
Four Day
2 wk.
4 wk.
Zero Delay
2 wk.
Immobile
2 & 4 wk.
0
4
10
14
18
24
Total Days of Loading Treatment (Load Days)

4 wk.
28

Table 5. 3: Illustrates how each level of the third factor; Load (days) - total of daily loading treatments, is
nested within a separate level of the first factor, Delay (days) - the delay in onset of the loading protocol.

Motivated by my expectation for a significant effect on tendon-to-bone healing of the large
number of treatment days, 24 in total, incurred by the four-week, four-day-delayed group, I performed
three separate single linear regressions to explore how maximum load, yield load and linear slope
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changed in response to the seven levels of the single factor, total loading days (Load days), using
SigmaPlot 10 software, Plots of these three regressions, including their significance, are shown in
Figures 5.8, 5.9 and 5.10.
For correlations to the yield load and yield elongation the distribution of these two response
variables was not normal (Figure 5.11A). However, distributions of the maximum load and maximum
elongation variables were normally distributed (Figure 5.11B).
Multiple linear regression (MLR) was applied to the collective load-to-failure data from all 63
subjects (Minitab 17). The results are shown in Table 5.5. These 63 datasets were then sorted by their
site of failure, to disclose any relationship between the mechanisms of failure and the experimental
treatments. The sites of failure were separated as either; pull-out from femoral bone tunnel; pull-out
from tibial bone tunnel, mid-substance tendon graft rupture, or failure through the physis.
A second MLR was performed using only subjects that failed via bone tunnel pull-out; either
femoral, tibial or both tunnels (total N = 54), after removing mid-substance graft rupture and physis
fracture, from the collective of datasets, Table 5.6 .
The third MLR was performed after removing simultaneous failures from both tunnels from the
collective, leaving only femoral and tibial tunnel failures (N = 42), Table 5.7.
The final and fourth MLR was performed after the removal all femoral tunnel failures leaving
only tibial tunnel failures (N = 26), Table 5.8. The total of four mid substance failures was judged too
small to provide any significant analysis.
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A.

Figure 5.7A-C: Typical load-elongation mechanical tensile tests for the rat bone tunnel-tendon-bone
tunnel complex. Successful fits for load-elongation data with (A) an exponential growth model and (B) a
linear model. (C) While neither an exponential or a linear model was a good fit, the linear model was
chosen for final data analysis. The shape of the load-elongation response probably represents a
combination of tendon and tunnel responses.
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5.7B

5.7C
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Table 5.4 Exponential and Linear Curve Fit Results of Load to Failure Data. Page 1 of 3
Delay Load Group
Exponential Fit
P-value P-value Linear Fit Yield Elong- Max ElongFailure
Treat (days) (days) (days) Rat No.
Coeff. "a" Coeff "b"
a
b
Slope
Load ation Load ation
Site
Continuous Immobilization 2 Weeks N/(μm) N/(μm)
N/(μm)
(N)
(μm)
(N)
(μm)
Immb 0
14
14 R82
11.10 5.28E-04 0.096 0.072 6.39E-03 2.64
420 5.56
1,294 Fem-Tnl.
Immb 0
14
14 R85
4.52 3.89E-04 0.014 0.006 1.98E-03 1.57
786 2.21
1,494 Fem-Tnl.
Immb 0
14
14 R86-B
3.22 8.55E-04 0.000 0.000 4.83E-03 8.42
1,568 8.82
1,836 Fem-Tnl.
Immb 0
14
14 R87
13.61 2.96E-04 0.000 0.000 4.67E-03 6.15
1,289 6.88
1,683 Fem-Tnl.
Immb 0
14
14 R88
0.39 2.14E-03 0.000 0.000 1.73E-03 1.63
788 1.91
1,510 Fem-Tnl.
Immb 0
14
14 R83
9,625.69 4.49E-07 0.999 0.999 4.32E-03 1.75
451 1.94
628 Tib-Tnl.
Immb 0
14
14 R84
35,097.10 1.53E-07 0.994 0.994 6.39E-03 5.26
1,024 5.26
1,024 Both Tnl.s
Continuous Immobilization 4 Weeks
Immb 0
14
14 R89
72.74 3.86E-05 0.026 0.022 2.89E-03 5.99
2,009 6.27
2,187 Fem-Tnl.
Immb 0
14
14 R98
96.34 1.02E-04 0.011 0.009 1.02E-02 8.36
807 9.70
1,079 Fem-Tnl.
Immb 0
14
14 R91
8.42 5.41E-04 0.000 0.000 5.83E-03 6.82
1,143 7.35
1,812 Tib-Tnl.
Immb 0
14
14 R105
14.66 4.66E-04 0.000 0.000 8.16E-03 8.30
971 10.30
1,575 Tib-Tnl.
Immb 0
14
14 R106
11,267.61 3.15E-07 0.982 0.982 3.55E-03 8.88
2,445 8.96
2,533 Both Tnl.s
Immb 0
14
14 R102
17.68
2.87E-04
0.997 0.997 5.55E-03 4.64
819 5.13
996 Mid-Subs
Immediate Distraction 2 Weeks
Load
1
13
14 R101
558.15 1.23E-05 0.987 0.987 6.92E-03 4.70
697 5.52
1,769 Fem-Tnl.
Load
1
13
14 R104
7.32 4.63E-04 0.000 0.000 4.17E-03 4.86
1,142 6.32
1,929 Fem-Tnl.
Load
1
13
14 R93
0.19 2.57E-03 0.000 0.000 1.51E-03 1.89
958 2.18
2,082 Tib-Tnl.
Load
1
13
14 R103
607.40 6.35E-06 0.998 0.998 3.86E-03 1.84
514 3.07
1,970 Tib-Tnl.
Load
1
13
14 R107B
1.22 1.31E-03 0.000 0.000 2.78E-03 3.17
997 4.33
1,800 Tib-Tnl.
Load
1
13
14 R108
827.48 4.73E-06 0.996 0.996 3.92E-03 3.14
831 5.16
4,664 Both Tnl.s
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Table 5.4 Exponential and Linear Curve Fit Results of Load to Failure Data. Page 2 of 3
Delay Load Group
Treat (days) (days) (days) Rat No.
Immediate Distraction 4 Weeks
Load
1
27
28 R90
Load
1
27
28 R92
Load
1
27
28 R94
Load
1
27
28 R96
Load
1
27
28 R97
Load
1
27
28 R99
Load
1
27
28 R100
4 Day Delayed-Distraction 2 Weeks
Load
4
10
14 R35-04-10
Load
4
10
14 R42-04-10
Load
4
10
14 R22-04-10
Load
4
10
14 R38-04-10
Load
4
10
14 R33-04-10
Load
4
10
14 R45-04-10
Load
4
10
14 R46-04-10
Load
4
10
14 R44-04-10
4 Day Delayed-Distraction 4 Weeks
Load
4
24
28 R49-04-10
Load
4
24
28 R10-04-10
Load
4
24
28 R19-04-10
Load
4
24
28 R47-04-10
Load
4
24
28 R48-04-10
Load
4
24
28 R51-04-10
Load
4
24
28 R8-10-10
Load
4
24
28 R18-04-10
Load
4
24
28 R20-04-10
Load
4
24
28 R50-04-10

Failure
Exponential Fit
P-value P-value Linear Fit Yield Elong- Max ElongCoeff. "a" Coeff "b"
a
b
Slope
Load ation Load ation
Site
N/(μm) N/(μm)
N/(μm)
(N)
(μm)
(N)
(μm)
725.79 6.05E-06 0.996 0.996 4.40E-03 6.05
1,382 6.61
1,678 Tib-Tnl.
43.97 1.06E-04 0.436 0.436 4.78E-03 2.60
534 3.03
748 Tib-Tnl.
8.21 5.04E-04 0.000 0.000 5.58E-03 8.97
1,473 9.96
1,685 Tib-Tnl.
1,851.29 5.60E-06 0.998 0.998 1.04E-02 5.44
588 8.61
1,679 Tib-Tnl.
6.02 6.73E-04 0.000 0.000 6.25E-03 11.06
1,568 13.09
2,291 Tib-Tnl.
152.11 1.26E-05 1.000 1.000 1.92E-03 0.65
360 0.68
481 Tib-Tnl.
10.30 4.24E-04 0.000 0.000 4.95E-03 3.78
757 4.18
907 Both Tnl.s
9,103.05
8.22
71,451.53
24,089.28
10.15
12.76
19,339.05
14.09

1.24E-07
1.14E-04
5.22E-08
1.48E-07
7.50E-05
1.85E-04
2.94E-07
3.47E-04

0.993
0.270
0.992
0.995
0.000
0.000
0.998
0.000

0.993
0.237
0.992
0.995
0.000
0.000
0.998
0.000

1.13E-03 2.43
1.00E-03 1.58
3.73E-03 7.99
3.55E-03 3.47
8.33E-04 2.72
2.85E-03 7.71
5.68E-03 3.93
6.11E-03 10.39

2,113 2.64
1,629 1.86
2,261 8.05
1,024 3.60
3,151 5.99
2,595 8.41
741 5.26
1,633 13.77

2,438
2,647
2,558
1,174
6,534
3,080
1,095
4,272

Fem-Tnl.
Fem-Tnl.
Tib-Tnl.
Tib-Tnl.
Both Tnl.s
Both Tnl.s
Both Tnl.s
Tib-Physis

5.21
8.16
54.83
0.64
232.13
3.20
8.82
116,373.0
4.71
45,361.28

4.39E-04
4.93E-04
9.98E-05
1.74E-03
4.17E-05
8.35E-04
3.19E-04
8.65E-08
7.57E-04
3.47E-07

0.000
0.000
0.000
0.000
0.013
0.000
0.000
0.994
0.000
0.999

0.000
0.000
0.000
0.000
0.012
0.000
0.000
0.994
0.000
0.999

3.16E-03
5.29E-03
5.93E-03
2.52E-03
9.92E-03
5.44E-03
3.32E-03
1.01E-02
6.32E-03
1.57E-02

1,830
1,389
2,099
1,066
1,450
1,980
1,334
1,536
1,800
514

2,391
1,596
2,401
1,456
1,965
2,642
2,694
3,038
1,979
1,492

Fem-Tnl.
Tib-Tnl.
Tib-Tnl.
Tib-Tnl.
Tib-Tnl.
Tib-Tnl.
Both Tnl.s
Both Tnl.s
Both Tnl.s
Tib-Physis

6.33
8.08
12.78
3.38
14.51
13.43
4.70
14.86
13.38
6.21

7.67
8.82
14.20
4.50
15.15
19.39
5.99
15.78
14.83
11.16
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Delay Load Group
Treat (days) (days) (days) Rat No.
10 Day Delayed-Distraction 2 Weeks
Load 10
4
14 R12-10-10
Load 10
4
14 R15-10-10
Load 10
4
14 R19-10-10
Load 10
4
14 R47-10-10
Load 10
4
14 R14-10-10
Load 10
4
14 R18-10-10
Load 10
4
14 R21-10-10
Load 10
4
14 R53-10-10
Load 10
4
14 R17-10-10
Load 10
4
14 R20-10-10
10 Day Delayed-Distraction 4 Weeks
Load 10
18
28 R26-10-10
Load 10
18
28 R34-10-10
Load 10
18
28 R38-10-10
Load 10
18
28 R55-10-10
Load 10
18
28 R56-10-10
Load 10
18
28 R35-10-10
Load 10
18
28 R27-10-10
Load 10
18
28 R41-10-10
Load 10
18
28 R42-10-10

Table 5.1 Exponential and Linear Curve Fit Results of Load to Failure Data. Page 3 of 3
Exponential Fit
P-value P-value Linear Fit Yield Elongation Max Elongation Failure
Coeff. "a" Coeff "b"
a
b
Slope Load (N) (μm) Load (N) (μm)
Site
N/(μm)
N/(μm)
N/(μm) (N)
(μm)
(N)
(μm)
3.99 7.39E-04 0.000 0.000 5.77E-03 14.51
2,126 14.51
2,126 Fem-Tnl.
25,300.11 3.52E-07 0.999 0.999 8.91E-03 3.66
472 6.18
1,566 Fem-Tnl.
26,824.84 2.55E-07 0.997 0.997 6.84E-03 4.98
775 5.87
3,700 Fem-Tnl.
1.03 1.01E-03 0.000 0.000 2.01E-03 3.66
1,522 7.28
2,740 Fem-Tnl.
30,567.06 1.75E-07 0.998 0.998 5.34E-03 4.06
833 5.50
3,032 Tib-Tnl.
3.50 7.76E-04 0.000 0.000 4.69E-03 9.01
1,681 9.50
1,803 Tib-Tnl.
148.95 5.87E-05 0.117 0.110 8.94E-03 8.85
995 11.19
1,389 Tib-Tnl.
34,921.57 2.01E-07 0.998 0.998 7.02E-03 5.35
853 7.81
3,005 Both Tnl.s
6.76 4.55E-04 0.000 0.000 4.97E-03 14.38
2,557 14.38
2,557 Mid-Subs
28.16 2.45E-04 0.000 0.000 7.72E-03 9.47
1,203 10.56
1,599 Mid-Subs
0.66
5.79
19,098.50
2.72
14,074.33
15,821.83
2.25
5.23
92,699.47

1.33E-03
6.04E-04
1.88E-07
5.31E-04
2.22E-07
5.70E-07
1.28E-03
5.87E-04
6.97E-08

0.000
0.000
0.998
0.000
0.995
0.999
0.000
0.000
0.995

0.000
0.000
0.998
0.000
0.995
0.999
0.000
0.000
0.995

2.88E-03 7.84
5.15E-03 9.16
3.60E-03 4.76
2.26E-03 5.26
3.12E-03 2.64
7.61E-03 2.83
5.06E-03 4.52
4.65E-03 8.85
6.46E-03 13.46

1,947 9.07
1,572 10.91
1,301 4.76
2,044 5.82
865 3.04
341 3.75
872 5.16
1,723 9.90
2,106 14.66

2,249
1,907
1,301
2,254
1,409
552
1,083
3,516
2,605

Tib-Tnl.
Tib-Tnl.
Tib-Tnl.
Tib-Tnl.
Both Tnl.s
Mid-Subs
MdSB/T-Tn
MdSB/T-Tn
MdSB/F-Tn
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Figure 5.8: Linear regression of Maximum Load plotted against the number of loading treatment days.
Note that the relationship of the two did not prove significant.
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Figure 5.9: Linear regression of Yield Load plotted against the number of loading treatment days.
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Figure 5.10: Linear Slope versus loading days. In either case the relationship did not prove significant.
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A

B

Figure 5.11 A: Frequency of yield load data. B: Frequency of maximum load data. The responses for
maximum Load approached a normal distribution while those for yield load did not.
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Mechanical Properties
Multiple Linear Regression Results
Response
A
B
Slope M
Yield Load
Yield dist
Max Load
max dist

Constant
4,846.00
No Terms

P
0.239

0.00335

0.003

2.16
1,169.00
3.14
2,762.00

0.167
0.000
0.066
0.000

All failure modes, N = 63
Factors
Delay (days)
1096

0.226
31.2
0.25

P
0.118

0.054
0.123
0.049

P

Study(days)

0.000084

0.083

0.1547

0.021

0.1602
-33.7

0.028
0.065

Table 5.5: Regression results for all 63 subjects, regardless of site or method of failure.
The first multiple MLR examined all 63 data-sets independent of failure site (Table 5.5). Stepwise
regression at a significance level of α = 0.15 for inclusion of terms produced the following equations
predicting coefficient “a” of the exponential model and the slope of the linear model:
a = 4846 + 1096 Delay (days);

F2,61 = 2.52, p = 0.118, r2 = 3.97%,

Slope = 0.00335 + 0.000084 Study (days);

F2,61 = 3.12, p = 0.083, r2 = 4.86%,

However the effect of the independent variable was insignificant in each equation above, with (Delay
(days); p = 0.118 and Study (days); p = 0.083.

For the maximum load, stepwise regression (α = 0.15) resulted in the following equation:
Max (N) = 3.14 + 0.250 Delay (days) + 0.1602 Study (days);

F3,60 = 4.47, p = 0.016, r2 = 12.96%

With significant effects for independent variables Delay (day); p = 0.049 and Study (days); p = 0.028.

Stepwise regression (α = 0.15) also produced the following similar equation for the yield load:
Yield (N) = 2.16 + 0.226 Delay (days) + 0.1547 Study (days); F3,60 = 4.65, p = 0.013, r2 = 13.43%
Here the variable Delay (day) was almost significant, p = 0.054, while Study (days) was, with p = 0.028.
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Multiple Linear Regression
Response
A

Constant
No terms

B

No terms

Slope M

No terms

Yield Load
0.91
Yield dist No terms
Max Load
1.80
max dist
1,831.00

P

Tunnel failures: Tibial, Femoral or both, N = 54
Factors
Delay (days)
P
Study(days)
P

0.563

0.18

0.150

0.2164

0.002

0.299
0.000

0.227
56.3

0.100
0.114

0.2209

0.004

Table 5.6: Regression results reflecting tunnel failures only, N= 54, after removal of mid-substance,
combined mid-substance/tunnel and physis failures from the collective of datasets.

For the second MLR (Table 5.6) all mid-substance tendon graft failures, combined midsubstance/tunnel and physis failures (n=9) were removed from the sample to focus solely on all sites of
tunnel failure; femoral, tibial or both tunnels together. An α level of 0.15 prevented the inclusion of any
of the independent variables in the attempts to build models predicting either the coefficients of the
exponential model or the slope of the linear model.

The second MLR did produce a significant equation predicting maximum load:
Maximum (N) = 1.80 + 0.227 Delay (days) + 0.2209 Study (days); F3,51 = 5.56, p = 0.006, r2 = 18.15%
Here independent variable Delay (days) was not significant (p=0.100), while the variable Study
(days) was significant (p=0.004) for the prediction of maximum load.

A similar equation was produced for the yield load:
Yield load (N) = 0.91 + 0.180 Delay (days) + 0.2164 Study (days); F3,51 = 6.04, p = 0.004, r2 = 19.15%
Again, Delay (days) was not significant (p=0.150), while Study (days) remained significant (p = 0.002).
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Multiple Linear Regression
Response
A

Constant
12,909.00

B

No terms

Slope M

No terms

Yield Load
Yield dist
Max Load
max dist

0.72
678.00
1.24
1,619.00

P
0.056

0.679
0.016
0.527
0.000

Femoral or Tibial Tunnels Only, N = 42
Factors
Delay (days)
P
Study(days)
838
0.100
-526

0.239
46.8
0.278
65.4

0.076
0.028
0.066
0.006

0.212
19.1
0.2352

P
0.068

0.007
0.106
0.007

Table 5.7: Regression results reflecting femoral or tibial tunnel failures only, after removal of failures
through both tunnels.

The third MLR (Table 5.7) removed failures through both tunnels from the sample to focus solely
on femoral and tibial tunnel failures. Stepwise inclusion resulted in an equation predicting coefficient
“a” of the exponential model, but failed to produce an equation for coefficient “b”, nor one predicting
the slope of the linear model.
A = 12909 + 838 Delay (days) - 526 Study (days);

F3,39 = 3.46, p = 0.041, r2 = 15.07%

Neither independent variable was significant in the above; Delay (days) p= 0.100, Study (days) p = 0.068

The third MLR also produced significant equations for the maximum and yield loads.
Max (N) = 1.24 + 0.278 Delay (days) + 0.2352 Study (days);

F3,39 = 5.40, p = 0.009, r2 = 21.68%

Variable Delay (days) p= 0.066 was insignificant, while variable Study (days) p = 0.007 was significant.
Yield (N) = 0.72 + 0.239 Delay (days) + 0.2120 Study (days);

F3,39 = 5.40, p = 0.009, r2 = 21.67%

Variable Delay (days) p= 0.076 was insignificant, while variable Study (days) p = 0.007 was significant.
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Multiple Linear Regression
Response
A

Constant
29,025.00

B

No terms

Slope M

No terms

Yield Load
Yield dist
Max Load
max dist

1.75
479.00
2.01
1,570.00

Tibial Tunnel Only, N = 26
P
0.009

0.503
0.207
0.517
0.000

Factors
Delay (days)

P

63.9

0.018

49.9

0.111

Study(days)
-990

P
0.028

0.209
22.1
0.248

0.061
0.138
0.630

Table 5.8: Regression results reflecting tibial tunnel failures only.

The last MLR (Table 5.8) looked at tibial tunnel failures alone (N = 26). Again stepwise inclusion
resulted in an equation for the coefficient “a” of the exponential model, but not for coefficient “b”, or
the slope of the linear model.
a = 29025 - 990 Study (days);

F2,24 = 5.44, p = 0.028, r2 = 18.49%

Variable Study (days) was significant with p = 0.028.

In the equations for yield load and maximum load, the α level of 0.15 prevented stepwise
regression from including a term for the number of Delay (days):
Maximum (N) = 2.01 + 0.248 Study (days);

F2,24 = 3.81, p = 0.063, r2 = 13.69%

However variable Study (days) was no longer significant p = 0.63.
Yield load (N) = 1.75 + 0.209 Study (days);

F2,24 = 3.85, p = 0.061, r2 = 13.82%

Independent variable Study (days) was no longer significant, with p = 0.61 in the above equation.
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Discussion
The objective of Chapter Five was to identify the optimum time-frame to begin postoperative
knee rehabilitation exercise in the rat model of ACL-R. This required the manipulation of several
experimentally controlled variables including the delay period prior to beginning daily loading
treatments (Delay (days)), the study length (Study (days)) and the actual number of treatment days
(Load (days)). Multiple linear regressions were used to assess the effect of each independent variable in
predicting the mechanical properties (maximum load, yield load and load-elongation model), of the
reconstructed femur-tendon graft-tibia construct, and to tease out any association between these
variables and the mode or site of failure.

The first MLR analyzed all data sets independent of failure site. It did not reveal any significant
relationship between the experimental variables and the load-elongation relation (stiffness) of the
construct, whether described by either the exponential “Fung” model or a linear model. This is not
surprising considering the variety of failure modes across all 63 subjects (Figures 5.7 A-C), and the
possible effect of friction between the tendon graft and tunnel as the tendon pulled through bone
tunnels.
However both the Delay (days) and Study (days) variables had a significant effect as shown in
the following regression model predicting the magnitude of the maximum load:

Maximum Load (N) = 3.14 + 0.250 Delay (days) + 0.1602 Study (days);

Equation. 1

Note the effect of Delay (days) was roughly 1.56 times greater (N/day) than that of the number of study
days. This supports the hypothesis that an initial period of load shielding prior to daily loading is more
significant to increase the maximum load of the ACL-R. Considering that the factor Delay (days) remains
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fixed from the start of the study, its predicted effect on maximum load could be visualized as three
separate plots, one for each delay period group, of the maximum load at failure versus study length
(Figure 5.12).
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4

Delay 10 days

2
0
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Figure 5.12: Plot of the expected effect of delay period on maximum load as predicted by equation 1.

Equation 1 partially explains the results of Bedi et al. (Figure 5.13), who in the initial publication
of these data reported that the group beginning loading after a delay of 10 days achieved a mean
maximum load of 9.6 (N) at the end of the 14 day study, more than double the 4.4 (N) means of the
group loaded daily from day 1, and the immobilized group (p < 0.01).
However, while equation 1 would predict a greater maximum load for a 10 day delay over a 4
day delay period, Bedi et al. found that the 4 day delay group of the 28 day study achieved a mean
maximum load of 13.5 (N), significantly greater than the 10 day delay and all other groups (Figure 5.13,
p = 0.01). This implies there is a limit to the additive effect of the Delay (days) variable of equation 1,

118

which increases from zero to a peak in magnitude somewhere around the 4 day time-point, then begins

Load to Failure (N)

to decline to day ten.

Figure 5.13: Plot of the maximum loads of all four treatment groups. At 2 weeks the 4 and 10 day
delayed groups show increased maximum load as predicted by Equation 1.
However, at 4 weeks, mean of the 4 day delayed group is significantly greater than all other
groups, while the 10 day delay group is not significantly different from the others, contradicting
equation 1. (From the first publication of these data by Bedi et al.) The asterisk indicates p = 0.01.
The second MLR removed all mid-substance/and or physis failures from the sample. As before
neither the exponential coefficients nor linear slope had a significant relationship with the experimental
variables. The Delay (days) factor was no longer significant in the regression equation for maximum load
(p = 0.01), leaving only study days as a significant factor (p = 0.004).
Maximum Load (N) = 1.8 + 0.227 Delay (days) + 0.2209 Study (days);

Equation 2

The effect of Delay (days) has decreased to 1.03 times the effect of Study (days) in Equation 2,
so removing mid-substance failures from the sample set has equalized the predictive effect of Delay
119

(days) and Study (days) on the maximum load. Failures by mid-substance indicate that the graft
insertions have held up long enough for the load to exceed the strength of the tendon graft, their
exclusion removes 9 data sets with a mean maximum load of 9.8 Ns from the sample and could explain
the reduced maximum load predicted by equation 2.
Prior to the third MLR, we removed 12 failures via “both tunnels” from the sample set. This only
slightly increased the effect of Delay (days) to 1.18 that of Study (days) in the regression equation for
maximum load, although Delay (days) remained non-significant (p = 0.066). The “a” coefficient for the
exponential model just missed significance (p = 0.056).

Max (N) = 1.24 + 0.278 Delay (days) + 0.2352 Study (days);

Equation 3

For the fourth MLR, femoral tunnel failures were removed to focus solely on tibial tunnel
failures. This further reduced the significance of the Delay (days) term, bringing it above the α level for
inclusion in the model, and also resulted in the loss of significance of the Study (days) variable (p =
0.630), in the regression equation for maximum load

Maximum (N) = 2.01 + 0.248 Study (days);

Equation 4

Separation according to failure site into separate populations analyzed by subsequent MLR did
not produce any significant models predicting the mechanical parameters of the femur-graft-tibia
construct, for any specific failure type; whether mid-substance failure, femoral tunnel or tibial tunnel
pull-out. Although the first MLR produced a significant equation for yield load, similar to that of
maximum load, the non-normal distribution of the yield load sample population (Figure 5,11B) violates
the assumptions of MLR, and invalidates further predictive modeling of the yield load.
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Despite my expectation for an effect of the different number of loading days between treatment
groups (the Load-days variable in Table 5.4), it failed to reach the α-level of significance required for
initial inclusion in any of the models produced by the MLRs. Future studies should consider equalizing
this factor across groups; such as 4 and 10 day delay period groups, each receiving a subsequent 20 days
of loading treatments, for a total study length of 24 and 30 days respectively. Six unloaded days could be
added at the end of 4 day delay group, to equal the 30 day study length of the 10 day group, should
prolonged study length prove to have an effect equal or greater to loading.
The fact that the 4 day delay group at 28 days achieved the largest mean maximum load, despite
the Equation 1 predicting this for the 10 day group, suggests nonlinear behavior of the Delay (days)
variable with a peak around four days. For a better estimate of the optimum immobilization period
duration prior to post ACL-R knee re-mobilization, future studies could use non-linear regression, with
the magnitude of the Delay (days) variable modeled as a bell curve centered close to four days. Ideally
this would result in increased significance of the resulting regression equations predicting the
mechanical parameters of the treated ACL-R.

A possible explanation of the mechanism behind the Delay (days) factor in equation 1, is the
increased bone volume, mineral content and density of the tibial tunnel in both the 4 and 10 day
delayed loading groups (micro-CT results of Table 5.2). The delay periods are associated with greater
bone ingrowth into the tunnel, increasing contact with and friction on the graft tendon, resulting in
greater loads required for failure of the femur-tendon graft-tibia construct.
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Chapter 6

Effect of immediate and delayed high-strain loading on tendon-to-bone healing after anterior
cruciate ligament reconstruction

The results of chapter five show that post ACL_R, adding a four to ten day immobilization period
(load shielding) prior to the onset of the daily loading protocol (cyclic knee distraction), improves tendon
to bone healing. Because the group receiving four days of immobilization prior to daily loading achieved
a significantly higher failure load, we decided not to continue the ten day initial immobilization group.
Instead, chapter VI will determine the effect of increasing graft strain to 10 %. We continued using the
more effective (for this rat model) 4 day immobilization period prior to beginning daily loading on
postoperative day 4, to a distance calculated to achieve 10% graft strain.

H2, the modified hypothesis governing chapter VI states: post ACL_R surgery, after an initial four
day period of load shielding, daily sessions of high-strain tensile graft loading will improve tendon graft
to bone tunnel healing, compared to either continuous load shielding or immediate onset tensile graft
loading.
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Methods
With IACUC approval, seventy male Sprague Dawley rats weighing from 300 to 380 grams
underwent the identical ACL reconstruction procedure and knee immobilizing ex-fix placement
described in chapter IV and V. These rats were then randomly assigned among three experimental
groups: (1) Continuous immobilization, (2) Immediate 10 % cyclic tendon graft strain, daily beginning on
postoperative day 1, and (3) Delayed onset 10 % cyclic graft strain beginning on postoperative day 4.
As the study progressed thirty five animals needed to be sacrificed prematurely due to; infection
(n=7), complications with anesthesia (n=4) and fracture of the limbs undergoing distraction (n=24). Upon
dissection prior to load to failure testing, an additional nine specimens were discovered to have failed
tendon grafts, with five occurring in the immediate loading group alone. The final group totals were;
eight specimens of continuous-immobilization, seven of immediate-loading and eleven of the delayedloading on day four, (figure 6.1).
Continuous
immobilization
Days 1 -14
70 SD Rats
Receive
ACL_R
Surgery

Immediate Loading
10 % Strain
Days 1 - 14

Immobilized
Days 1 - 3

Day 0

n=8

Postoperative day: 1

n=7

Loading Begins
10 % Strain
Days 4 - 14

4

n = 11
Losses:
Fracture (24)
Anesthesia (4)
Infections (7)
Graft failure (9)
14
Sacrifice

Figure 6.1: Study Design
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Daily Knee Distraction Protocol
The animals were anesthetized and placed in the CDM to receive fifty cycles of cyclic knee
distraction as previously described in chapter four. For this study of high strain, 10 % of the average
graft length of 15 mm equated to 1.5 mm. Knee joint distraction to this distance was achieved using the
compliance correction factor for the CDM with coupled ex-fix calculated in chapter III [115], and the
average slack length from the cadaver study of chapter IV, in the following formula:
Knee Distraction = LVDT (mm) – Load (N) * Compliance (mm/N) – average slack length (mm)
Here compliance = 42.4 µm/N, and average graft slack length = 0.55 mm
Upon study commencement an initial high incidence of fractures during joint distraction
necessitated imposition of a load limit of 2,400 N on the CDM system. Thereafter the CDM distracted
the knee joint at 0.24 mm/sec until the target distance of 1.5 mm, or the load limit was reached, then
returned the joint to the starting position for the next cycle.
Micro-Computed Tomography Analysis
Micro-CT scanning of the tibia specimens was performed, focused on a cylindrical volume of
interest of 3.4 mm diameter along the length of the tibial bone tunnel, using the procedure detailed in
chapter four. Bone formation and remodeling were evaluated with five quantitative measures: new
bone volume (mm3), tissue mineral content (mg), tissue mineral density (mg/mL), trabecular thickness
(µm), and trabecular number.

Figure 6.2: Micro-CT image of the tibial tunnel; and its division into
three cylindrical regions for analysis; intra-articular aperture, mid-tunnel,
and extra-articular aperture [117].
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Biomechanical Testing
The biomechanical testing procedure was previously detailed in chapters IV and V. Briefly, limb
specimens were thawed and dissected until only the femur-graft-tibia complex remained. Both tibia and
femur were potted and securely mounted in the grips of a custom tensile test machine, with the bone
tunnel axes parallel to test machine translation.
After five cycles of preconditioning from 0 to 0.2 N load, elongation to failure of the femur-graft
tibia complex proceeded at 10 mm per minute. The stiffness (N/mm) and ultimate load (N) were
calculated from the load-displacement relation. The site and of mode failure (tunnel pull-out or midsubstance graft rupture) were noted.

Statistical Analysis
Two way analysis of variance followed by a post hoc Tukey test was used to find significant
differences, (p < 0.05) among group data from the micro-CT and biomechanical data.

Results
Micro-CT
Both cyclic distraction loaded groups had significantly higher tissue mineral density in new bone
through the entire tibial tunnel; with the four-day delayed-loading at 586 mg/ml and immediate-loading
at 589.7 mg/ml, versus continuous-immobilization with 571 mg/ml, (p < 0.05). The four-day delayedloading group showed significantly greater tissue mineral density around the distal-tunnel, extraarticular aperture (813.0 mg/mL), than either the immediate-loading (778.4 mg/mL) or continuousimmobilization group (784.9 mg/mL), (p < 0.05), (Table 6.I) [117].
The continuous-immobilization and the four-day delayed-loading groups had bone volume
fractions (bone volume / total volume) that appeared greater than the immediate loading group; 0.24
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and 0.23 compared to 0.20, (Table 6.1 and figure 6.2). The continuous-immobilization group also had a
trabecular thickness in the mid-tunnel region that was significantly greater than the immediate-loading
group, (106.5 versus 72.6 mm, p < 0.01) [117].
No significant differences were found for; bone volume (p = 0.241), new-bone volume (p =
0.331), trabecular spacing (extra-articular: p = 0.723, mid-tunnel: p = 0.331, intra-articular: p = 0.542), or
trabecular number (extra-articular: p= 0.538, mid-tunnel: p= 0.272, intra-articular: p= 0.317) [117].

Biomechanical Testing
No significant differences in failure load (p = 0.366) or stiffness (p = 0.247) were found.
The mean failure loads by group were (N):
Continuous-immobilization 7.8 ± 2.3; immediate-loading 6.5 ± 1.6; delayed- loading 6.4 ± 2.4
And mean stiffness by group (N/mm):
Continuous-immobilization 3.0 ± 0.3; immediate- loading 3.5 ± 1.3; delayed- loading 4.2 ± 1.6, [117]

Figure 6.3 Biomechanical testing results showing no significant differences between groups in the
failure load or stiffness of the femur-graft-tibia construct [117].
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Table 6.1: Summary of Micro-CT Data for the Tibial Tunnels
Group

Continuous
Immobilization

Immediate
Distraction

4-Day Delayed
Distraction

571.0 ± 3.6
819.4 ± 26.8
784.9 ± 26.4
794.7 ± 32.7
837.3 ± 65.6

589.7 ± 14.8‡
827.0 ± 17.2
778.4 ± 32.6
776.3 ± 35.0
845.4 ± 45.9

586.5 ± 12.7‡
837.9 ± 29.2
813.0 ± 24.9‡§
792.0 ± 45.8
852.6 ± 52.8

Bone volume/total volume (total bone)
Entire tunnel
0.24 ± 0.03
Extra-articular aperture
0.18 ± 0.06
Mid-tunnel
0.15 ± 0.07
Intra-articular aperture
0.27 ± 0.12

0.20 ± 0.05
0.22 ± 0.26
0.13 ± 0.07
0.24 ± 0.07

0.23 ± 0.06
0.15 ± 0.08
0.10 ± 0.06
0.21 ± 0.10

Bone volume/total volume (new bone only)
Entire tunnel
0.13 ± 0.02
Extra-articular aperture
0.069 ± 0.020
Mid-tunnel
0.069 ± 0.030
Intra-articular aperture
0.090 ± 0.030

0.11 ± 0.02
0.057 ± 0.022
0.057 ± 0.023
0.071 ± 0.025

0.12 ± 0.03
0.069 ± 0.031
0.066 ± 0.027
0.079 ± 0.021

Tissue mineral density (mg/ml)
Entire tunnel (new bone)
Entire tunnel (total bone)
Extra-articular aperture
Mid-tunnel
Intra-articular aperture

Trabecular number (avg./mm)
Extra-articular aperture
Mid-tunnel
Intra-articular aperture

2.67 ± 0.47
3.07 ± 0.65
3.62 ± 0.78

2.49 ± 0.48
2.47 ± 0.60
3.16 ± 1.15

2.95 ± 1.20
2.88 ± 0.80
3.19 ± 1.11

Trabecular thickness (μm)
Extra-articular aperture
Mid-tunnel
Intra-articular aperture

99.0 ± 21.8
106.5 ± 23.0
143.8 ± 27.9

83.8 ± 16.0
72.6 ± 10.6#
120.6 ± 25.4

99.5 ± 24.0
89.7 ± 21.6
127.8 ± 27.9

‡Significantly different from immobilized group (p < 0.05).
§Significantly different from immediate-loading group (p < 0.05).
#Significantly different from immobilized group (p < 0.01).
J Bone Joint Surg Am. 2014 May 7; 96(9): 770–777.

[117]
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Figure. 6.4: Axial micro-CT images of the tibia tunnel; A) continuous-immobilization, B) immediateloading, and C) delayed- loading. Three-dimensional reconstructions of the tibia tunnel, sagittal views;
D) continuous-immobilization, E) immediate- loading, and F) delayed high-strain loading [117].
Discussion
Although this study shares several parameters with chapter five, including the use of immediate
and four day delayed-loading groups, its goal was not to investigate temporal delays, but rather to
determine the effect of a higher magnitude of strain on tendon to bone healing. High graft strains are
clinically relevant, current ACL_R techniques such as trans-tibial drilling of the femoral bone tunnel
result in non-anatomic and non-isometric graft placement, meaning that upon knee flexion the relative
rotation and displacement of the tunnel apertures elongates the healing graft.
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The micro-CT data partly supports our hypothesis, with the four-day delayed-loading group
showing significantly greater tissue mineral density in the distal tibial tunnel. Both the delayed- loading
and immobilization groups showed a trend toward greater bone volume and trabecular thickness.
However neither the immediate nor four-day delayed- loading group showed improved biomechanical
properties or bone structural properties than the continuous immobilization group.
This is in contrast with the findings of chapter V where a smaller 2 % graft strain was applied. In
that study the four day delayed-loading group showed superior results to the both the immobilized and
the ten day delayed- loading groups. This comparison implies that the benefits of a four day delay
before the onset of knee joint distraction have been offset by the order of magnitude increase in graft
strain.
This study was particularly challenging as evidenced by the number of animals lost prematurely.
Each of the 50 daily 1.5 mm distractions of the knee joint placed large bending loads on the k-wire pins
used to secure the ex-fix to the bone, precipitating fractures, pin loosening and infections. Placement of
the 2,400 gram load limit was necessary to reduce fractures, but as the soft tissue surrounding the graft
healed over time, load across the joint space increased, resulting in some subjects not reaching the 1.5
mm target distance. Therefore we cannot guarantee reproducible graft strains across animals.
This study did show impairments in trabecular bone remodeling when comparing immediate
postoperative onset high graft strain (immediate-loading) with both continuous immobilization and a
four day immobilization period prior to the onset of high graft strain (delayed-loading). However this
result did not correlate with failure load of the femur-graft-tibia construct. These results support our
previous finding of the effectiveness of a four day period of pre strain immobilization and argue for
human ACL rehabilitation programs consisting of a brief immobilization period followed initially by
exercises that limit the amount of applied graft strain.
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Chapter 7: Conclusion

To investigate the effect of tensile loading protocols on tendon graft to bone tunnel healing, we
developed and validated a novel device to distract the knee joint in a rat model of ACL_R, thereby
imposing tensile strain on the graft within. To our knowledge this is the first time a controlled amount of
mechanical stimulation has been applied to an animal model of tendon graft implantation. Our goal is to
enhance our understanding of tendon to bone healing and apply the knowledge gained to the design
and development of improved rehabilitation protocols that effect more robust and functional ligament
reconstructions and tendon repairs.
Exposure to tensile loading has been shown to maintain tendon/ligament homeostasis, with the
tensile modulus of the tissue increasing in response to greater loading frequency or even decreasing in
its absence. However after injury or surgical repair the effect of tensile load is less clear, with many
studies implicating mechanical loading with impaired healing, particularly in the case of torn rotator cuff
tendon. Clinicians need to know when they can safely reintroduce tensile strain on a healing repair, and
ideally choose the time point when it can most benefit the remodeling process.

In Chapter IV we investigated the effect of beginning tendon graft strain immediately after
ACL_R surgery, by starting daily sessions of knee joint distraction on postoperative day one (the
immediate-loading group), and comparing the effect with strain shielded rats whose ACL_R knees were
immobilized by continuous wearing of the ex-fix (the continuous-immobilization group). Although we
did not see any significant differences in structural properties or new bone formation between the two
groups there was a significant increase in inflammatory, ED1 antigen positive [118] macrophages from
circulation in the two-week immediate- loading group. This result partly supported the hypothesis that
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an immediate onset of tensile strain on postoperative day one would impair healing, as evidenced by an
increased influx of inflammatory cells. Overall there was no measureable difference in the strength of
the reconstruction between the immediate- loading group and continuous-immobilization group.
In Chapter V we explored the effect of delaying the onset of postoperative tendon graft strain by
inserting either a four or ten day period of immobilization, enforced by the ex-fix, prior to beginning the
daily knee distraction protocol (the four or ten-day delayed-distraction groups). These results supported
the hypothesis that a four to ten day immobilization period prior to graft strain would improve tendon
to bone healing, with both the four and ten-day delayed-loading groups showing more new bone
formation in the tendon-tunnel interface, fewer inflammatory macrophages and a greater failure load
and stiffness than the continuous-immobilization and immediate loading groups. The four-day delayedloading group ending on postoperative day 28 had a remarkably high failure load of 13.5 N which
compares relatively well after only four weeks of healing to the roughly 30 – 40 N failure load of the
native ACL of this species reported in the literature and experienced in our laboratory.
For chapter VI we shifted our focus from varying the temporal onset to determining the effect of
an order of magnitude increase in strain, by augmenting the joint distraction distance from two to ten
percent of original tendon graft length (using the compliance correction of chapter III). Due to the
superior performance of the four-day delayed- loading group in chapter V and an increased rate of
fractures, we did not repeat the ten-day delayed- loading n group.
Both ten-percent strain knee distraction groups, the immediate- loading (postoperative day one)
and the four-day delayed-loading group had a significantly greater tissue mineral density than the
continuous-immobilization group. The four-day delayed-loading group also had a significantly higher
tissue mineral density around the distal tibial tunnel exit, than either the immediate-loading or
continuous-immobilization groups. However the continuous-immobilization group had a trabecular
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thickness in the mid tunnel region significantly greater than the immediate-loading group. Overall the
net effect of the increase in graft strain to 10 % appeared negligible as there was no significant
difference in the load to failure or stiffness of the femur-graft-tibia construct between all three groups.
Apparently the effect of the four-day delay prior to daily cyclic knee distraction, which correlated with
such a marked increase in the load to failure of the four-day delayed-loading group of chapter V, was
somehow negated by the greater strain magnitude.

In a previous study our lab histologically documented the postoperative cell population within
the tendon-bone tunnel interface, again using a rat model of ACL_R, but without immobilization or knee
distraction. A rapid influx of neutrophils proceeded through the interface and into the tendon graft,
peaking in population by postoperative day four and receding by day seven. This coincided with an
increasing population of ED1+ macrophages in the interface that remained elevated from days 11
through 21. However resident ED2+ macrophages did not appear in the interface until day 11 where they
reached a peak population by day 14 to remain at this level through the end of the study on day 28
[119].

Comparing the above with the current data from chapters IV and V one sees a significantly
greater number of ED1+ macrophages in both the continuous-immobilization and immediate-distraction
groups at both the 14 and 28 day time points. Presumably the three to four day lifespan neutrophil
population receded long before sacrifice. It appears that these treatments are prolonging the
inflammatory and proliferative phases of the wound healing process. In contrast, both the four and tenday delayed-loading groups show a significantly greater number of ED2+ macrophages, appearing as if
these groups had progressed into the remodeling phase of the healing process.
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One explanation for the relatively poor performance of the immediate-loading group in chapter
IV may be that the lack of an initial immobilization period never allows the inflammatory phase of
wound healing to resolve. Instead initiation of knee distraction on postoperative day one continually
ruptures coagulations before blood vessels heal, resulting in a prolonged recruitment of catabolic ED1+
macrophages from circulation. This is reflected in the higher levels of ED1+ cells counted in this group
than in the four and ten-day delayed-loading groups. The catabolic nature of the ED1+ macrophage could
result in its continual removal of ECM material from the interface and necrotic graft tendon tissue,
possible accounting for the reduced failure load and stiffness in this group. In chapter VI the superphysiologic level of strain could also prolong the inflammatory-catabolic phase of heal and account for
the lack of a difference in failure loads between groups.

The addition of four and ten day immobilization periods to strain shield the graft would allow
time for healing to progress beyond the coagulation and inflammation phases and into the proliferation
and remodeling phases. Accumulation of sufficient numbers of fibrocytes, and resident ED2 antigen
positive macrophages with the potential to differentiate into osteoblast and osteoclast cells could result
in the deposition of greater quantities of ECM material into the tendon-tunnel interface. Upon the
beginning of cyclic knee distraction, the lower two-percent level of tensile strain could potentially guide
these cells in remodeling the interface tissue along the predominant orientation of tensile stress, and
account for the greater load to failure of the four- and ten-day delayed- loading groups of chapter V.

Out of all the rehabilitation protocols for the rat model of ACL_R described in this dissertation,
the one judged most effective on the basis of greatest failure load and stiffness, most bone ingrowth,
and lowest inflammatory cell population, is the four-day delayed-loading protocol of chapter V. It can be
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equated to initial three to four days of postoperative knee immobilization, followed by a knee motion
beginning on postoperative day four, that reliably imposes 2 % tendon graft strain, repeated for 50 daily
repetitions until postoperative day 28.
Extrapolating the above parameters from the rat model may prove difficult. Perhaps the
changeover in macrophage population from circulating to resident could provide a clue as to when to
end the immobilization period and begin a knee mobilization/graft strain regime in a human clinical trial.
A 2-4 % strain has been reported to occur in the human ACL from the activities of daily living, and
exercises duplicating these activities applied in the trial. Flexion limiting knee braces are currently
prescribed after ACL_R and could be used to impose a short period of knee immobilization. Therefore
clinical trials of protocols utilizing initial immobilization periods are possible.

There are limitations in the transfer of knowledge acquired from the studies described herein.
In-vivo loading of the native ACL is complex and consists of components of tension, compression, torsion
and shear, while the knee distraction utilizes uniaxial tension alone, the most reliably controlled and
quantified method available to us for this small animal model. Distraction could have potentially added
to the resulting inflammation, particularly in the high strain study of chapter VI. Additional structures
were severed during surgery to prevent their initial stress shielding of the graft tendon. Bleeding and
release of cytokines and other bioactive factors from these structures would undoubtedly affect the
healing response.
Future work in tendon to bone healing by our group has already begun. In response to concerns
over the high rate of fractures engendered by the ex-fix bone pins while under load during knee
distraction, I designed a second tendon graft loading system that elongates the graft via a subcutaneous
pull wire. Here only a partial ACL_R is performed with one end of the graft secured in a lone femoral
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bone tunnel, its opposite end terminates in a free floating bone block, from which a trans-cutaneous
pull will applies tension to the graft during experimental sessions. A paper describing the initial results
achieved with this device is expected to be published in this fall.
Need for a more clinically relevant rat model of ACL_R rehabilitation that more faithfully
replicates common knee extension exercises resulted in my design of a rat knee flexion device [120].
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